JP3207285B2 - New methotrexate derivatives - Google Patents

New methotrexate derivatives

Info

Publication number
JP3207285B2
JP3207285B2 JP04430193A JP4430193A JP3207285B2 JP 3207285 B2 JP3207285 B2 JP 3207285B2 JP 04430193 A JP04430193 A JP 04430193A JP 4430193 A JP4430193 A JP 4430193A JP 3207285 B2 JP3207285 B2 JP 3207285B2
Authority
JP
Japan
Prior art keywords
compound
general formula
added
solvent
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP04430193A
Other languages
Japanese (ja)
Other versions
JPH05339268A (en
Inventor
宏治 松岡
裕史 鈴木
伸明 加藤
敬一郎 辻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP04430193A priority Critical patent/JP3207285B2/en
Publication of JPH05339268A publication Critical patent/JPH05339268A/en
Application granted granted Critical
Publication of JP3207285B2 publication Critical patent/JP3207285B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、新規なメトトレキセー
ト誘導体、更に詳しくは、抗リウマチ剤として有用な新
規なメトトレキセート誘導体に関する。
The present invention relates to a novel methotrexate derivative, and more particularly, to a novel methotrexate derivative useful as an antirheumatic agent.

【0002】[0002]

【従来の技術・発明が解決しようとする課題】メトトレ
キセートは古くより白血病の治療薬として用いられてき
たが、1951年Gubnerらが慢性関節リウマチ
(RA)や乾癬に用いて有効性を報告して以来RAの治
療薬として欧米で使用されてきた。比較的最近になっ
て、用法、用量の詳細な検討が実施され、低用量メトト
レキセート療法が比較的副作用が少なく、しかも優れた
有効性を発揮することが明らかになってきた。しかしメ
トトレキセート服用により生ずる肝障害や肺繊維化等の
副作用も無視できないため、さらに副作用が少なく、か
つ効力の優れた薬物の登場が望まれている。
2. Description of the Related Art Methotrexate has been used as a therapeutic agent for leukemia for a long time, but in 1951, Gubner et al. Reported its efficacy in rheumatoid arthritis (RA) and psoriasis. Since then, it has been used in Europe and the United States as a therapeutic agent for RA. More recently, detailed studies of dosage and administration have revealed that low-dose methotrexate therapy has relatively few side effects and exhibits excellent efficacy. However, since side effects such as liver damage and pulmonary fibrosis caused by taking methotrexate cannot be ignored, there is a demand for a drug with less side effects and excellent efficacy.

【0003】本発明者らは、メトトレキセート誘導体に
おいて抗リウマチ作用面でより優れた化合物を求めて鋭
意研究をし、本発明をなすに至った。
[0003] The present inventors have conducted intensive studies in search of a compound having a better antirheumatic effect in a methotrexate derivative, and have accomplished the present invention.

【0004】[0004]

【課題を解決するための手段】本発明は、下記一般式
(I)
The present invention provides a compound represented by the following general formula (I):

【化2】 式中、R1は、炭素数1乃至4の低級アルキル基を示
し; R2は、炭素数1乃至4の低級アルキル基またはトリフ
ルオロメチル基を示し; R3は、水素原子または炭素数1乃至4の低級アルキル
基またはトリフルオロメチル基を示し; R4は、水素原子または炭素数1乃至4の低級アルキル
基を示し; nは1から4までの整数を示し; R5は、一般式COOR6(ここでR6は水素原子または
炭素数1乃至4の低級アルキル基を示す)で表される基
またはSO3Hで表される基を示す; で示されるメトトレキセート誘導体(但し、R1がメチ
ル基、R2がトリフルオロメチル基、R3が水素原子、R
4が水素原子、nが2、R5がCOOR6(R6が水素原
子)である化合物を除く)を提供するものである。
Embedded image In the formula, R 1 represents a lower alkyl group having 1 to 4 carbon atoms; R 2 represents a lower alkyl group having 1 to 4 carbon atoms or a trifluoromethyl group; R 3 represents a hydrogen atom or a 1 carbon atom. R 4 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; n represents an integer of 1 to 4; R 5 represents a general formula COOR 6 (wherein R 6 represents a hydrogen atom or a lower alkyl group having a carbon number of 1 to 4) a group represented by the group or SO 3 H expressed by; methotrexate derivative represented by (wherein, R 1 Is a methyl group, R 2 is a trifluoromethyl group, R 3 is a hydrogen atom, R
4 is intended to provide a hydrogen atom, n is 2, R 5 is COOR 6 except Compound (R 6 is a hydrogen atom) is).

【0005】本発明の化合物は、いずれも文献未載の新
規化合物であり、たとえば以下の様にして合成される。 (方法A)
The compounds of the present invention are novel compounds which have not been published in any literature, and are synthesized, for example, as follows. (Method A)

【化3】 Embedded image

【0006】(方法B)(Method B)

【化4】 (式中、R、R、R、R、Rおよびnは前記
と同じ意味を示し、R′は炭素数1乃至4の低級アルキ
ル基を示し、AおよびAは保護基を示し、Xはハロ
ゲン原子を示す。)
Embedded image (Wherein, R 1 , R 2 , R 3 , R 4 , R 5 and n have the same meaning as described above, R ′ represents a lower alkyl group having 1 to 4 carbon atoms, and A 1 and A 2 are protected X represents a halogen atom.)

【0007】方法Aにおいて、一般式(1)の化合物か
ら一般式(2)の化合物を得る反応は、例えば炭酸水素
ナトリウム、炭酸カルシウム、炭酸カリウム等の共存
下、水−メタノール、水−エタノール、水−プロパノー
ル等の混合溶媒中、一般式(1)の化合物と式Xで示
されるハロゲンを反応させることにより行う。一般式X
としてはフッ素、塩素、臭素、ヨウ素等が挙げられる
が、一般式(1)の化合物においてRまたはRがト
リフルオロメチルである場合、反応させるハロゲンはヨ
ウ素が好ましい。
In the method A, the reaction for obtaining the compound of the general formula (2) from the compound of the general formula (1) is carried out, for example, in the presence of sodium hydrogen carbonate, calcium carbonate, potassium carbonate and the like in the presence of water-methanol, water-ethanol, water - a mixed solvent such as propanol, carried out by reacting the halogen represented by a compound of formula X 2 in the general formula (1). General formula X
Examples of 2 include fluorine, chlorine, bromine, iodine and the like. When R 2 or R 3 in the compound of the general formula (1) is trifluoromethyl, the halogen to be reacted is preferably iodine.

【0008】一般式(2)の化合物から一般式(3)の
化合物を得る反応は、一般式(2)の化合物と無水酢酸
を、トルエン、ベンゼン、キシレン、ジオキサン、ピリ
ジン等の溶媒中反応させることにより行う。尚、一般式
(1)の化合物から一般式(2)の化合物を得るまでの
工程と、一般式(2)の化合物から一般式(3)の化合
物を得るまでの工程は逆になっていてもよい。
In the reaction for obtaining the compound of the general formula (3) from the compound of the general formula (2), the compound of the general formula (2) is reacted with acetic anhydride in a solvent such as toluene, benzene, xylene, dioxane or pyridine. It is done by doing. The steps from the compound of the general formula (1) to the compound of the general formula (2) and the process from the compound of the general formula (2) to the compound of the general formula (3) are reversed. Is also good.

【0009】一般式(3)の化合物から一般式(4)の
化合物を得る反応は、一般式(3)の化合物とシアン化
銅を例えば、N−メチルピロリドン、ジメチルホルムア
ミド、ジメチルアセトアミド、ジメチルプロピレンウレ
ア、ヘキサメチルホスホリックトリアミド等の溶媒中反
応させることにより行う。
In the reaction for obtaining the compound of the general formula (4) from the compound of the general formula (3), the compound of the general formula (3) and copper cyanide are, for example, N-methylpyrrolidone, dimethylformamide, dimethylacetamide, dimethylpropylene The reaction is performed in a solvent such as urea and hexamethylphosphoric triamide.

【0010】一般式(4)の化合物から一般式(5)の
化合物を得る反応は、一般式(4)の化合物と12N−
塩酸、50%−水酸化ナトリウム水溶液等を反応させる
ことにより行う。
The reaction for obtaining the compound of the general formula (5) from the compound of the general formula (4) is carried out by reacting the compound of the general formula (4) with 12N-
The reaction is performed by reacting hydrochloric acid, a 50% aqueous solution of sodium hydroxide, or the like.

【0011】一般式(5)の化合物と一般式(6)の化
合物から一般式(7)の化合物を得る反応は、メタノー
ル、エタノール等のアルコール中、塩酸または硫酸の共
存下で反応させることにより行う。また、アルコール中
塩化チオニルの共存下で行ってもよい。式中R′で示さ
れるアルキル基としては、メチル基、エチル基等が好ま
しい。
The reaction for obtaining the compound of the general formula (7) from the compound of the general formula (5) and the compound of the general formula (6) is carried out in an alcohol such as methanol or ethanol in the presence of hydrochloric acid or sulfuric acid. Do. Alternatively, the reaction may be carried out in the presence of thionyl chloride in alcohol. As the alkyl group represented by R 'in the formula, a methyl group, an ethyl group and the like are preferable.

【0012】一般式(7)の化合物と一般式(8)の化
合物から一般式(9)の化合物を得る反応は、一般式
(7)の化合物をピリジン等の溶媒に溶解または水素化
ナトリウムの共存下、テトラヒドロフラン、ジメチルホ
ルムアミド、ジメトキシエタン、ジオキサン、トルエン
等に懸濁させ、一般式(8)の化合物を加え、攪拌する
ことにより行う。式中Aで示される保護基としては、
例えばp−トルエンスルホニル基、ベンジルオキシカル
ボニル基、アセチル基等が挙げられる。
The reaction for obtaining the compound of the general formula (9) from the compound of the general formula (7) and the compound of the general formula (8) is carried out by dissolving the compound of the general formula (7) in a solvent such as pyridine or sodium hydride. The reaction is carried out by suspending in tetrahydrofuran, dimethylformamide, dimethoxyethane, dioxane, toluene or the like in the coexistence, adding the compound of the general formula (8), and stirring. In the formula, the protecting group represented by A 1 includes
For example, a p-toluenesulfonyl group, a benzyloxycarbonyl group, an acetyl group and the like can be mentioned.

【0013】一般式(9)の化合物と一般式(10)の
化合物から一般式(11)の化合物を得る反応は、一般
式(9)の化合物を例えば無水ジメチルホルムアミド、
テトラヒドロフラン、ジメトキシエタン、ジオキサン等
に溶解させ、氷冷下、例えば水素化ナトリウムを加え1
0℃〜120℃、好ましくは室温で攪拌した後、一般式
(11)の化合物を加え、10℃〜120℃、好ましく
は室温で攪拌することにより行う。
In the reaction for obtaining a compound of the general formula (11) from a compound of the general formula (9) and a compound of the general formula (10), the compound of the general formula (9) is converted into, for example, anhydrous dimethylformamide,
It is dissolved in tetrahydrofuran, dimethoxyethane, dioxane or the like, and added with, for example, sodium hydride under ice-cooling.
After stirring at 0 ° C to 120 ° C, preferably at room temperature, the compound of the general formula (11) is added, and the mixture is stirred at 10 ° C to 120 ° C, preferably at room temperature.

【0014】一般式(11)の化合物から一般式(1
2)の化合物を得る反応は、一般式(11)の化合物を
メタノール、エタノール、テトラヒドロフラン等の溶媒
中、水酸化カリウム、水酸化ナトリウム水溶液等の共存
下、10℃〜100℃、好ましくは室温で反応させるこ
とにより行う。
From the compound of the general formula (11), the compound of the general formula (1)
In the reaction for obtaining the compound of 2), the compound of the general formula (11) is reacted in a solvent such as methanol, ethanol or tetrahydrofuran in the presence of potassium hydroxide, an aqueous sodium hydroxide solution or the like at 10 ° C to 100 ° C, preferably at room temperature. The reaction is carried out.

【0015】一般式(12)の化合物から一般式(1
3)の化合物を得る反応は、一般式(12)の化合物を
塩化チオニル、オキサリルクロリド等の酸ハロゲン化剤
に懸濁し、触媒量のジメチルホルムアミド等の共存下、
室温で撹拌することにより行う。
From the compound of the general formula (12), the compound of the general formula (1)
In the reaction for obtaining the compound of 3), the compound of the general formula (12) is suspended in an acid halogenating agent such as thionyl chloride, oxalyl chloride and the like, and is suspended in the presence of a catalytic amount of dimethylformamide or the like.
It is performed by stirring at room temperature.

【0016】一般式(13)の化合物と一般式(14)
の化合物から一般式(15)の化合物を得る反応は、一
般式(13)の化合物をジクロロメタン等の溶媒に溶解
したものを、氷冷下または水冷下で一般式(14)の化
合物の水溶液に加え、炭酸カリウム、水酸化ナトリウ
ム、炭酸水素ナトリウム等の無機塩基の共存下、室温で
撹拌することにより行う。
The compound of the general formula (13) and the compound of the general formula (14)
In the reaction for obtaining the compound of the general formula (15) from the compound of the formula, a solution of the compound of the general formula (13) in a solvent such as dichloromethane is added to an aqueous solution of the compound of the general formula (14) under ice cooling or water cooling. In addition, the reaction is carried out by stirring at room temperature in the presence of an inorganic base such as potassium carbonate, sodium hydroxide and sodium hydrogen carbonate.

【0017】一般式(15)の化合物から一般式(1
6)の化合物を得る反応は、アニソールやフェノール等
を臭化水素−酢酸溶液に溶解した溶液に一般式(15)
の化合物を加え、10℃〜60℃好ましくは室温で撹拌
することにより行う。また、Aがカルボベンゾキシ基
の場合、この一般式(15)の化合物から一般式(1
6)の化合物を得る反応は、一般式(15)の化合物を
メタノールやエタノール、酢酸等の溶媒に溶解させ、パ
ラジウム−炭素を加えた後、水素雰囲気下室温にて撹拌
することにより行ってもよい。
From the compound of the general formula (15), the compound of the general formula (1)
The reaction for obtaining the compound of the formula 6) is performed by dissolving anisole or phenol in a solution of hydrogen bromide-acetic acid according to the general formula (15).
And stirring at 10 ° C. to 60 ° C., preferably at room temperature. When A 1 is a carbobenzoxy group, the compound of the general formula (15)
The reaction for obtaining the compound of 6) may be carried out by dissolving the compound of the general formula (15) in a solvent such as methanol, ethanol or acetic acid, adding palladium-carbon, and then stirring at room temperature under a hydrogen atmosphere. Good.

【0018】一般式(16)の化合物と一般式(17)
の化合物から一般式(I)の化合物を得る反応は、一般
式(16)の化合物と一般式(17)の化合物をジメチ
ルアセトアミド、ジメチルホルムアミド等の溶媒中、0
℃〜100℃好ましくは50℃〜60℃で撹拌して行
う。特にRが水素原子である場合は、さらにメタノー
ルやエタノール、テトラヒドロフラン等の溶媒に1N−
水酸化ナトリウム水溶液を加え、0℃〜60℃好ましく
は35℃で撹拌して目的物を得る。
The compound of the general formula (16) and the compound of the general formula (17)
In the reaction for obtaining the compound of the general formula (I) from the compound of the formula (I), the compound of the general formula (16) and the compound of the general formula (17) are dissolved in a solvent such as dimethylacetamide, dimethylformamide or the like.
C. to 100.degree. C., preferably 50.degree. Especially when R 4 is a hydrogen atom, further methanol or ethanol, in a solvent such as tetrahydrofuran 1N-
An aqueous solution of sodium hydroxide is added, and the mixture is stirred at 0 ° C to 60 ° C, preferably at 35 ° C to obtain the desired product.

【0019】方法Bにおいて、一般式(5)の化合物と
一般式(18)の化合物から一般式(19)の化合物を
得る反応は、一般式(5)の化合物と一般式(18)の
化合物の懸濁液を0℃〜100℃好ましくは室温で反応
させることにより行う。式中、Aで示される保護基と
しては、トリフルオロアセチル基、アセチル基等が挙げ
られる。
In the method B, the reaction of obtaining the compound of the general formula (19) from the compound of the general formula (5) and the compound of the general formula (18) comprises the compound of the general formula (5) and the compound of the general formula (18) The reaction is carried out at 0 ° C to 100 ° C, preferably at room temperature. Wherein the protecting group represented by A 2, trifluoroacetyl group, and a acetyl group.

【0020】一般式(19)の化合物と一般式(20)
の化合物から一般式(21)の化合物を得る反応は、一
般式(19)の化合物と一般式(20)の化合物のアセ
トン溶液に水酸化カリウムを加え、0℃〜55℃、好ま
しくは45℃〜53℃で撹拌することにより行う。
The compound of the general formula (19) and the compound of the general formula (20)
Is obtained by adding potassium hydroxide to an acetone solution of the compound of the general formula (19) and the compound of the general formula (20), and adding 0 to 55 ° C., preferably 45 ° C. Perform by stirring at ~ 53 ° C.

【0021】一般式(21)の化合物から一般式(2
2)の化合物を得る反応は、一般式(21)の化合物を
水中で水酸化カリウムまたは水酸化ナトリウムと反応さ
せることにより行う。ここで一般式(21)の化合物の
かわりに前述の一般式(11)の化合物を用いてもよ
い。
From the compound of the general formula (21), the compound of the general formula (2)
The reaction for obtaining the compound of 2) is carried out by reacting the compound of the general formula (21) with potassium hydroxide or sodium hydroxide in water. Here, the compound of the above general formula (11) may be used instead of the compound of the general formula (21).

【0022】一般式(22)の化合物と一般式(17)
の化合物から一般式(23)の化合物を得る反応は、一
般式(22)の化合物と一般式(17)の化合物をジメ
チルアセトアミドやジメチルホルムアミド等の溶媒中、
0℃〜100℃、好ましくは40℃〜55℃で撹拌する
ことにより行う。
The compound of the general formula (22) and the compound of the general formula (17)
In the reaction for obtaining the compound of the general formula (23) from the compound of the general formula (23), the compound of the general formula (22) and the compound of the general formula (17) are dissolved in a solvent such as dimethylacetamide or dimethylformamide.
It is carried out by stirring at 0 ° C to 100 ° C, preferably at 40 ° C to 55 ° C.

【0023】一般式(23)の化合物と一般式(14)
の化合物から一般式(I)の化合物を得る反応は、一般
式(23)の化合物をジエチルリン酸シアニドやジシク
ロヘキシルカルボジイミドと1−ヒドロキシベンゾトリ
アゾール等の共存下、ジメチルホルムアミド、ジメチル
アセトアミド、N−メチルピロリジノン等の溶媒中撹拌
し、それぞれ活性エステル、混合酸無水物を調製した後
に、一般式(14)の化合物を加え、0℃〜200℃、
好ましくは10℃〜80℃で撹拌することにより行う。
または、一般式(23)の化合物にトリエチルアミンを
加え、次いでクロルギ酸イソブチルを加え、ジメチルホ
ルムアミド、ジメチルアセトアミド、N−メチルピロリ
ジノン等の溶媒中撹拌し、一般式(14)の化合物を加
え、−20℃〜50℃、好ましくは−10℃〜0℃で撹
拌することにより行う。特にRが水素原子である場合
は、更にメタノールやエタノール等の溶媒中、1N−水
酸化ナトリウム水溶液を加え、0℃〜60℃、好ましく
は室温で撹拌して目的物を得る。
The compound of the general formula (23) and the compound of the general formula (14)
The compound of general formula (I) is obtained by reacting the compound of general formula (23) with dimethylformamide, dimethylacetamide, N-methyl in the presence of cyanide diethylphosphate, dicyclohexylcarbodiimide and 1-hydroxybenzotriazole. After stirring in a solvent such as pyrrolidinone to prepare an active ester and a mixed acid anhydride, respectively, the compound of the general formula (14) is added, and the mixture is added at 0 ° C to 200 ° C.
It is preferably performed by stirring at 10 ° C to 80 ° C.
Alternatively, triethylamine is added to the compound of the general formula (23), then isobutyl chloroformate is added, the mixture is stirred in a solvent such as dimethylformamide, dimethylacetamide, N-methylpyrrolidinone, and the compound of the general formula (14) is added. C. to 50.degree. C., preferably -10.degree. In particular, when R 4 is a hydrogen atom, a 1N aqueous sodium hydroxide solution is further added in a solvent such as methanol or ethanol, and the mixture is stirred at 0 ° C. to 60 ° C., preferably at room temperature, to obtain the desired product.

【0024】[0024]

【作 用】本発明により得られた一般式(I)で示され
る化合物は、抗リウマチ作用を持つ。この作用は、以下
に示す実験例「ヒト末梢血を用いたリンパ球の増殖抑制
作用」を調べることにより確認した。
The compound represented by the general formula (I) obtained by the present invention has an antirheumatic effect. This effect was confirmed by examining the following experimental example "the effect of suppressing lymphocyte proliferation using human peripheral blood".

【0025】[0025]

【実施例】【Example】

「ヒト末梢血由来リンパ球の増殖抑制作用」 (方法)ヒト末梢血よりFicoll−Paque
用いてリンパ球を分離し、適度に希釈した薬物とそのリ
ンパ球10個をPHA(0.3μg/ml)とともに
2日間96穴culture plate中で培養し
た。培養終了後の5時間前にH−UdR(1μCi/
well)を加えリンパ球へのH−UdRの取り込み
をシンチレーションカウンターにて測定した。(ここで
PHAはphytohaemagglutinin、U
dRはdeoxyuridineを示す。)なお、用い
た薬物は下記のものである。
Lymphocytes were separated using a "growth inhibitory effects of human peripheral blood-derived lymphocyte" (Method) Ficoll-Paque R from human peripheral blood, moderately diluted drug and its lymphocyte 10 5 pieces of PHA (0.3 [mu] g / Ml) for 2 days in a 96-well culture plate. Five hours before the end of the culture, 3 H-UdR (1 μCi /
well) was added, and the uptake of 3 H-UdR into lymphocytes was measured using a scintillation counter. (Where PHA is phytohaemamagglutinin, U
dR indicates deoxyurdine. ) The following drugs were used.

【化5】 Embedded image

【0026】(結果、考察)図1に、薬剤非添加PHA
刺激リンパ球のH−UdR取り込みを100%とした
割合を示した。図1から明らかなように、本発明の化合
物は対照化合物より優れたリンパ球の増殖抑制作用(抗
リウマチ作用)を持つことが確認された。
(Results and Discussion) FIG.
The ratio is shown with the 3 H-UdR uptake of stimulated lymphocytes as 100%. As is clear from FIG. 1, it was confirmed that the compound of the present invention has a superior lymphocyte proliferation inhibitory action (anti-rheumatic action) than the control compound.

【0027】[0027]

【実施例】【Example】

【参考例1】N−カルボベンゾキシ−4−アミノ−3−メチル安息香
酸の合成
[Reference Example 1] N-carbobenzoxy-4-amino-3-methylbenzoate
Acid synthesis

【0028】4−アミノ−3−メチル安息香酸(5.0
g)を水(80ml)に懸濁させた後、この懸濁液に氷
冷下カルボベンゾキシクロライド(3.7g)のエーテ
ル溶液(20ml)と炭酸水素ナトリウム(3.6g)
を交互に加えた。2.5時間室温にて攪拌を続けた後、
更にカルボベンゾキシクロライド(3.7g)のエーテ
ル溶液(95ml)と炭酸水素ナトリウム(7.2g)
を氷冷下交互に加え1.5時間室温にて攪拌した。反応
液を4N−塩酸で酸性にした後、析出した不溶物を濾取
した。得られた固形物を真空乾燥した後、目的物(2.
8g)を得た。 H−NMR(CDCl,δ値):2.38(3H,
s),5.20(2H,s),7.41(5H,m),
7.97(3H,m)
4-amino-3-methylbenzoic acid (5.0
g) was suspended in water (80 ml), and the suspension was cooled in ice with an ether solution (20 ml) of carbobenzoxychloride (3.7 g) and sodium hydrogen carbonate (3.6 g).
Were added alternately. After stirring at room temperature for 2.5 hours,
Further, an ether solution (95 ml) of carbobenzoxychloride (3.7 g) and sodium hydrogen carbonate (7.2 g)
Were alternately added under ice-cooling, and the mixture was stirred at room temperature for 1.5 hours. After the reaction solution was acidified with 4N-hydrochloric acid, the precipitated insolubles were collected by filtration. After vacuum drying the obtained solid, the target substance (2.
8 g) were obtained. 1 H-NMR (CDCl 3 , δ value): 2.38 (3H,
s), 5.20 (2H, s), 7.41 (5H, m),
7.97 (3H, m)

【0029】[0029]

【参考例2】N−カルボベンゾキシ−N−メチル−4−アミノ−3−
メチル安息香酸メチルエステルの合成
Reference Example 2 N-carbobenzoxy-N-methyl-4-amino-3-
Synthesis of methyl benzoate methyl ester

【0030】水素化ナトリウム(1.4g)をジメチル
ホルムアミド(10ml)に懸濁させた後、この懸濁液
に参考例1の化合物(2.8g)のジメチルホルムアミ
ド溶液(10ml)を0℃にてゆっくりと加えた。反応
液を1時間室温にて攪拌した後、更にヨウ化メチルをゆ
っくりと加え、室温にて2時間攪拌した。次いで反応液
を飽和炭酸水素ナトリウム水溶液にあけ、トルエンを用
いて抽出した。硫酸ナトリウムで乾燥した後、減圧下に
溶媒を留去した。得られた残渣をシリカゲルカラムクロ
マトグラフィーに付し、溶出溶媒としてクロロホルムを
用い目的物(1.8g)を得た。 H−NMR(CDCl,δ値):2.19(3H,
s),3.19(3H,s),3.87(3H,s),
5.09(2H,s)7.21(6H,m),7.85
(2H,m)
After sodium hydride (1.4 g) was suspended in dimethylformamide (10 ml), a dimethylformamide solution (10 ml) of the compound of Reference Example 1 (2.8 g) was added to this suspension at 0 ° C. And slowly added. After the reaction solution was stirred at room temperature for 1 hour, methyl iodide was further added slowly, and the mixture was stirred at room temperature for 2 hours. Then, the reaction solution was poured into a saturated aqueous solution of sodium hydrogen carbonate, and extracted with toluene. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography, and chloroform was used as an elution solvent to obtain the desired product (1.8 g). 1 H-NMR (CDCl 3 , δ value): 2.19 (3H,
s), 3.19 (3H, s), 3.87 (3H, s),
5.09 (2H, s) 7.21 (6H, m), 7.85
(2H, m)

【0031】[0031]

【参考例3】N−カルボベンゾキシ−N−メチル−4−アミノ−3−
メチル安息香酸の合成 参考例2の化合物(1.8g)のエタノール(15m
l)溶液に2N−水酸化ナトリウム水溶液(15ml)
を加え、2時間還流した。次いで反応液を減圧下に濃縮
し10mlとした。4N−塩酸て酸性にした後クロロホ
ルムを用いて抽出し、硫酸ナトリウムで乾燥した。溶媒
を減圧下に留去し目的物(1.5g)を得た。 H−NMR(CDCl,δ値):2.02(3H,
s),3.04(3H,s),4.69(2H,s),
7.08(6H,m)7.77(2H,m)
Reference Example 3 N-carbobenzoxy-N-methyl-4-amino-3-
Synthesis of methylbenzoic acid Ethanol (15 m) of the compound of Reference Example 2 (1.8 g)
l) A 2N aqueous solution of sodium hydroxide (15 ml) was added to the solution.
Was added and refluxed for 2 hours. Then, the reaction solution was concentrated under reduced pressure to 10 ml. After acidifying with 4N hydrochloric acid, the mixture was extracted with chloroform and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain the desired product (1.5 g). 1 H-NMR (CDCl 3 , δ value): 2.02 (3H,
s), 3.04 (3H, s), 4.69 (2H, s),
7.08 (6H, m) 7.77 (2H, m)

【0032】[0032]

【参考例4】N−(N’−カルボベンゾキシ−N’−メチル−4−ア
ミノ−3−メチルベンゾイル)−L−グルタミン酸ジエ
チルエステルの合成 参考例3の化合物(820mg)を塩化チオニル(5m
l)に加えた後、更に、触媒量のジメチルホルムアミド
を添加し室温にて2時間攪拌した。次に反応液を減圧下
に濃縮乾固した。得られた固形物をジクロロメタン(2
0ml)に溶解させ、この溶液にグルタミン酸ジエチル
エステル塩酸塩(700mg)と炭酸カリウム(1.4
g)を加え、さらに水(20ml)を加え、室温にて激
しく12時間攪拌した。次に反応液を水にあけクロロホ
ルムを用い抽出し、1N−塩酸で洗浄した後硫酸ナトリ
ウムで乾燥した。溶媒を減圧下に留去した。得られた残
渣をシリカゲルクロマトグラフィーに付し、溶出溶媒と
してクロロホルム:メタノール=100:3の混合溶媒
を用い目的物(700mg)を得た。
Reference Example 4 N- (N′-carbobenzoxy-N′-methyl-4-a
Mino-3-methylbenzoyl) -L-glutamic acid die
Synthesis of tyl ester The compound of Reference Example 3 (820 mg) was converted to thionyl chloride (5 m
After adding to l), a catalytic amount of dimethylformamide was further added, and the mixture was stirred at room temperature for 2 hours. Next, the reaction solution was concentrated to dryness under reduced pressure. The solid obtained was diluted with dichloromethane (2
0 ml), and glutamic acid diethyl ester hydrochloride (700 mg) and potassium carbonate (1.4 mg) were added to the solution.
g) was added, and water (20 ml) was further added, followed by vigorous stirring at room temperature for 12 hours. Next, the reaction solution was poured into water, extracted with chloroform, washed with 1N hydrochloric acid, and dried over sodium sulfate. The solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel chromatography, and the desired product (700 mg) was obtained using a mixed solvent of chloroform: methanol = 100: 3 as an elution solvent.

【0033】H−NMR(CDCl,δ値):1.
1−1.5(6H,m),2.0−2.7(4H,
m),2.18(3H,s),3.19(3H,s),
3.9−4.4(4H,m),4.80(1H,m),
5.10(2H,s),7.0−7.5(6H,m),
7.63(2H,m)
1 H-NMR (CDCl 3 , δ value):
1-1.5 (6H, m), 2.0-2.7 (4H,
m), 2.18 (3H, s), 3.19 (3H, s),
3.9-4.4 (4H, m), 4.80 (1H, m),
5.10 (2H, s), 7.0-7.5 (6H, m),
7.63 (2H, m)

【0034】[0034]

【参考例5】N−〔N’−メチル−(4−アミノ−3−メチルベンゾ
イル)〕−L−グルタミン酸ジエチルエステルの合成 アニソール(700mg)を含む30%−臭化水素−酢
酸(7ml)溶液に参考例4の化合物(700mg)を
加え室温にて4時間攪拌した。次に反応液にエーテル
(200ml)を加えたところ赤褐色の油状物質が沈殿
した。大部分のエーテル層を除き油状物質をクロロホル
ムに懸濁させ、この懸濁液を飽和炭酸水素ナトリウム溶
液で洗浄し、有機層を分取した。有機層を硫酸ナトリウ
ムで乾燥した後、減圧下に溶媒を留去し目的物(360
mg)を得た。
Reference Example 5 N- [N'-methyl- (4-amino-3-methylbenzo)
Il)] Synthesis of diethyl L-glutamic acid The compound of Reference Example 4 (700 mg) was added to a 30% hydrogen bromide-acetic acid (7 ml) solution containing anisole (700 mg), and the mixture was stirred at room temperature for 4 hours. Next, ether (200 ml) was added to the reaction solution, and a red-brown oily substance precipitated. After removing most of the ether layer, the oily substance was suspended in chloroform. This suspension was washed with a saturated sodium hydrogen carbonate solution, and the organic layer was separated. After the organic layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure to obtain the desired product (360).
mg).

【0035】H−NMR(CDCl,δ値):1.
0−1.5(6H,m),2.11(3H,s),2.
90(3H,s),2.1−2.7(4H,m),3.
9−4.4(4H,m),4.80(1H,m),6.
54(1H,d,J=8Hz),6.80(1H,d,
J=7Hz),7.61(2H,m)
1 H-NMR (CDCl 3 , δ value):
0-1.5 (6H, m), 2.11 (3H, s), 2.
90 (3H, s), 2.1-2.7 (4H, m), 3.
9-4.4 (4H, m), 4.80 (1H, m), 6.
54 (1H, d, J = 8 Hz), 6.80 (1H, d,
J = 7 Hz), 7.61 (2H, m)

【0036】[0036]

【実施例1】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−メチルアミノ〕−3−メチルベン
ゾイル}−L−グルタミン酸ジエチルエステルの合成 参考例5の化合物(360mg)と6−ブロモメチル−
2,4−ジアミノプテリジン臭化水素酸塩イソプロパノ
ール付加物(407mg)をジメチルアセトアミド(6
ml)に懸濁し55−60℃で4時間攪拌した。冷却
後、反応液にトリエチルアミン(248mg)を含む水
(30ml)を加え攪拌し、次にクロロホルムで抽出し
た。クロロホルム層を硫酸ナトリウムで乾燥後、溶媒を
減圧にて留去し、得られた残渣をシリカゲルクロマトグ
ラフィーに付し、溶出溶媒としてクロロホルム:メタノ
ール=10:1の混合溶媒を用い目的物(280mg)
を得た。
Example 1 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-methylben
Synthesis of zoyl} -L-glutamic acid diethyl ester The compound of Reference Example 5 (360 mg) and 6-bromomethyl-
2,4-Diaminopteridine hydrobromide isopropanol adduct (407 mg) was added to dimethylacetamide (6
ml) and stirred at 55-60 ° C for 4 hours. After cooling, water (30 ml) containing triethylamine (248 mg) was added to the reaction solution, stirred, and then extracted with chloroform. After the chloroform layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography, using a mixed solvent of chloroform: methanol = 10: 1 as an elution solvent (280 mg).
I got

【0037】H−NMR(CDCl,δ値):1.
2−1.4(6H,m),2.0−2.6(4H,
m),2.41(3H,s),2.73(3H,s),
4.0−4.3(4H,m),4.32(2H,s),
4.76(1H,m),7.06(1H,d,J=8.
3Hz),7.41(1H,d,J=7.8Hz),
7.65(2H,m),8.79(1H,s)
1 H-NMR (CDCl 3 , δ value):
2-1.4 (6H, m), 2.0-2.6 (4H,
m), 2.41 (3H, s), 2.73 (3H, s),
4.0-4.3 (4H, m), 4.32 (2H, s),
4.76 (1H, m), 7.06 (1H, d, J = 8.
3 Hz), 7.41 (1H, d, J = 7.8 Hz),
7.65 (2H, m), 8.79 (1H, s)

【0038】[0038]

【実施例2】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−メチルアミノ〕−3−メチルベン
ゾイル}−L−グルタミン酸(化合物1)の合成 実施例1の化合物(280mg)のエタノール(20m
l)溶液に1N−水酸化ナトリウム水溶液(1.6m
l)を加え35℃で4時間攪拌した。次いで25℃で2
0時間攪拌した後、反応液に水(2ml)を加え減圧下
にこの反応液を乾固した。このとき外温は30℃を越え
ないようにした。得られた黄色固形物を水(10ml)
に溶解し、1N−塩酸でpH=3.7に調整し冷蔵庫の
中で2時間放置した。析出した沈殿物を濾取し目的物
(180mg)を得た。
Example 2 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-methylben
Synthesis of zoyl} -L-glutamic acid (compound 1) Ethanol (20m2) of the compound of Example 1 (280mg)
1) Add 1N-sodium hydroxide aqueous solution (1.6 m
l) was added and the mixture was stirred at 35 ° C for 4 hours. Then at 25 ° C 2
After stirring for 0 hour, water (2 ml) was added to the reaction solution, and the reaction solution was dried under reduced pressure. At this time, the external temperature was kept below 30 ° C. The obtained yellow solid was washed with water (10 ml).
And adjusted to pH = 3.7 with 1N-hydrochloric acid and left in a refrigerator for 2 hours. The deposited precipitate was collected by filtration to obtain the desired product (180 mg).

【0039】H−NMR(DMSO−d6,δ値):
1.9−2.2(2H,m),2.35(2H,t,J
=8.0Hz),2.42(3H,s),2.73(3
H,s),4.34(2H,s),4.41(1H,
m),7.10(1H,d,J=8.3Hz),7.7
2(2H,m),8.38(1H,d,J=7.8H
z),8.65(1H,s)
1 H-NMR (DMSO-d6, δ value):
1.9-2.2 (2H, m), 2.35 (2H, t, J
= 8.0 Hz), 2.42 (3H, s), 2.73 (3
H, s), 4.34 (2H, s), 4.41 (1H,
m), 7.10 (1H, d, J = 8.3 Hz), 7.7
2 (2H, m), 8.38 (1H, d, J = 7.8H
z), 8.65 (1H, s)

【0040】[0040]

【参考例6】N−カルボベンゾキシ−N−エチル−4−アミノ−3−
メチル−安息香酸エチルエステルの合成 窒素雰囲気下、ジメチルホルムアミド(2ml)に水素
化ナトリウム(164mg)を懸濁させ0℃とした。こ
の懸濁液にN−ベンジルオキシカルボニル−4−アミノ
−3−メチル安息香酸(650mg)のジメチルホルム
アミド溶液(2ml)をゆっくり加えた後、更に0℃に
て、ヨウ化エチル(730μl)をゆっくり加えた。室
温にて2.5時間攪拌を行った後、反応溶液で飽和炭酸
水素ナトリウム溶液中にあけ、トルエンで抽出した。ト
ルエン層を硫酸マグネシウムで乾燥させ減圧にて溶媒を
留去し、目的物(680mg)を得た。
Reference Example 6 N-carbobenzoxy-N-ethyl-4-amino-3-
Synthesis of methyl-benzoic acid ethyl ester Under a nitrogen atmosphere, sodium hydride (164 mg) was suspended in dimethylformamide (2 ml) and brought to 0 ° C. To this suspension was slowly added a solution of N-benzyloxycarbonyl-4-amino-3-methylbenzoic acid (650 mg) in dimethylformamide (2 ml), and then slowly added ethyl iodide (730 μl) at 0 ° C. added. After stirring at room temperature for 2.5 hours, the reaction solution was poured into a saturated sodium hydrogen carbonate solution, and extracted with toluene. The toluene layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product (680 mg).

【0041】H−NMR(CDCl,δ値):0.
91−1.63(6H,m),2.16(3H,s),
3.35−3.90(2H,m),4.10−4.55
(2H,m),5.07(2H,bs),6.95−
7.35(6H,m),7.68−7.95(2H,
m)
1 H-NMR (CDCl 3 , δ value):
91-1.63 (6H, m), 2.16 (3H, s),
3.35-3.90 (2H, m), 4.10-4.55
(2H, m), 5.07 (2H, bs), 6.95-
7.35 (6H, m), 7.68-7.95 (2H,
m)

【0042】[0042]

【参考例7】N−ベンジルオキシカルボニル−N−エチル−4−アミ
ノ−3−メチル安息香酸の合成 参考例6の化合物(680mg)のエタノール(5m
l)溶液に、2N−水酸化ナトリウム水溶液(5ml)
を加え2時間還流した。次いで、室温まで冷却し、減圧
にて反応溶液を乾固した。得られた残渣を少量の水に溶
解させ、エーテルで洗浄した後、濃塩酸を用いpH=3
とした。析出した沈殿物をクロロホルムを用い抽出し、
硫酸ナトリウムで乾燥した。溶媒を減圧にて留去し、目
的物(540mg)を得た。
Reference Example 7 N-benzyloxycarbonyl-N-ethyl-4-amido
Synthesis of no-3-methylbenzoic acid Ethanol (5m2) of the compound of Reference Example 6 (680mg)
l) To the solution, 2N-sodium hydroxide aqueous solution (5 ml)
Was added and refluxed for 2 hours. Then, the reaction solution was cooled to room temperature and dried under reduced pressure. The obtained residue was dissolved in a small amount of water, washed with ether, and then concentrated to pH 3 using concentrated hydrochloric acid.
And Extract the precipitated precipitate using chloroform,
Dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain the desired product (540 mg).

【0043】H−NMR(CDCl,δ値):1.
16(3H,t,J=5.4Hz),1.20(3H,
s),3.38−3.94(2H,m),5.12(2
H,bs),6.93−7.44(6H,m),7.7
2−8.08(2H,m)
1 H-NMR (CDCl 3 , δ value):
16 (3H, t, J = 5.4 Hz), 1.20 (3H,
s), 3.38-3.94 (2H, m), 5.12 (2
H, bs), 6.93-7.44 (6H, m), 7.7.
2-8.08 (2H, m)

【0044】[0044]

【参考例8】N−〔N’−エチル−3−メチル−(4−アミノベンゾ
イル)〕−L−グルタミン酸ジエチルエステルの合成 参考例7の化合物(500mg)を塩化チオニル(3m
l)に加えた後、更に触媒量のジメチルホルムアミドを
添加し、室温にて2時間攪拌した。次いで、反応液を減
圧にて濃縮乾固した。得られた固形物をジクロロメタン
(13ml)に溶解させ、この溶液にグルタミン酸ジエ
チルエステル(382mg)、炭酸カリウム(448m
g)を加え、さらに水(13ml)を加え、室温にて激
しく12時間攪拌した。反応液を飽和炭酸水素ナトリウ
ム水溶液にあけ、クロロホルムで抽出し、1N−塩酸で
洗浄後、硫酸ナトリウムで乾燥した。溶媒を減圧にて留
去し、無色の油状物質(830mg)を得た。次いで、
この得られた残渣(830mg)に、30%臭化水素−
酢酸(10ml)とアニソール(830mg)との混合
溶液を加え、室温で3時間攪拌した。反応後、大量のエ
ーテルを反応液に加えたところ暗褐色の油状物質が沈殿
した。大部分のエーテル層を除き、油状物質をクロロホ
ルムに懸濁させ、この懸濁液を飽和炭酸水素ナトリウム
水溶液で洗浄した。有機層を分取し、硫酸マグネシウム
で乾燥後、減圧にて溶媒を留去し、目的物(360m
g)を得た。
Reference Example 8 N- [N'-ethyl-3-methyl- (4-aminobenzo
Yl)]-L-glutamic acid diethyl ester The compound of Reference Example 7 (500 mg) was treated with thionyl chloride (3 m
After 1), a catalytic amount of dimethylformamide was further added, and the mixture was stirred at room temperature for 2 hours. Next, the reaction solution was concentrated to dryness under reduced pressure. The obtained solid was dissolved in dichloromethane (13 ml), and glutamic acid diethyl ester (382 mg) and potassium carbonate (448 m) were added to the solution.
g) was added, and water (13 ml) was further added, followed by vigorous stirring at room temperature for 12 hours. The reaction solution was poured into a saturated aqueous solution of sodium hydrogen carbonate, extracted with chloroform, washed with 1N hydrochloric acid, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain a colorless oil (830 mg). Then
30% hydrogen bromide- was added to the obtained residue (830 mg).
A mixed solution of acetic acid (10 ml) and anisole (830 mg) was added, and the mixture was stirred at room temperature for 3 hours. After the reaction, a large amount of ether was added to the reaction solution, and a dark brown oily substance precipitated. After removing most of the ether layer, the oily substance was suspended in chloroform, and this suspension was washed with a saturated aqueous solution of sodium hydrogen carbonate. The organic layer was separated, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure.
g) was obtained.

【0045】H−NMR(CDCl,δ値):1.
03−1.48(9H,m),1.83−2.62(7
H,m),2.96−3.43(2H,m),3.83
−4.40(4H,m),4.48−4.98(1H,
m),6.33−6.92(2H,m),7.34−
7.73(2H,m)
1 H-NMR (CDCl 3 , δ value):
03-1.48 (9H, m), 1.83-2.62 (7
H, m), 2.96-3.43 (2H, m), 3.83.
-4.40 (4H, m), 4.48-4.98 (1H,
m), 6.33-6.92 (2H, m), 7.34-
7.73 (2H, m)

【0046】[0046]

【実施例3】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−エチルアミノ〕−3−メチルベン
ゾイル}−L−グルタミン酸ジエチルエステルの合成 参考例8の化合物(360mg)と6−ブロモメチル−
2,4−ジアミノプテリジン臭化水素酸塩・イソプロパ
ノール付加物(342mg)のジメチルアセトアミド懸
濁液(10ml)を60℃で4時間攪拌した後、さらに
6−ブロモメチル−2,4−ジアミノプテリジン臭化水
素酸塩・イソブロパノール付加物(342mg)を加え
70℃で1.5時間攪拌した。次いで反応液を飽和炭酸
水素ナトリウム水溶液にあけ、クロロホルムで抽出し
た。クロロホルム層を硫酸マグネシウムで乾燥後、溶媒
を減圧にて留去し、得られた残渣をシリカゲルカラムク
ロマトグラフィーに付し、溶出溶媒として、クロロホル
ム:メタノール=10:1の混合溶媒を用い目的物(1
67mg)を得た。
Example 3 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-ethylamino] -3-methylben
Synthesis of zoyl} -L-glutamic acid diethyl ester The compound of Reference Example 8 (360 mg) and 6-bromomethyl-
A dimethylacetamide suspension (10 ml) of 2,4-diaminopteridine hydrobromide / isopropanol adduct (342 mg) was stirred at 60 ° C. for 4 hours, and then further treated with 6-bromomethyl-2,4-diaminopteridine bromide. A hydrochloride / isopropanol adduct (342 mg) was added, and the mixture was stirred at 70 ° C. for 1.5 hours. Then, the reaction solution was poured into a saturated aqueous solution of sodium hydrogen carbonate and extracted with chloroform. After the chloroform layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel column chromatography, using a mixed solvent of chloroform: methanol = 10: 1 as an elution solvent to obtain the desired compound ( 1
67 mg).

【0047】H−NMR(CDCl,δ値):1.
06(3H,t,J=8.0Hz),1.15−1.4
2(6H,m),1.76(3H,s),2.37−
2.54(4H,m),3.08(2H,q,J=8.
0Hz),4.10(2H,q,J=8.0Hz),
4.24(2H,q,J=8.0Hz),4.38(2
H,s),4.70−4.88(1H,m),5.32
(2H,bs),6.94(1H,d,J=7.4H
z),7.05(1H,d,J=8.8Hz),7.5
6(1H,d,J=5.2Hz),7.67(1H,b
s),8.80(1H,s)
1 H-NMR (CDCl 3 , δ value):
06 (3H, t, J = 8.0 Hz), 1.15-1.4
2 (6H, m), 1.76 (3H, s), 2.37-
2.54 (4H, m), 3.08 (2H, q, J = 8.
0 Hz), 4.10 (2H, q, J = 8.0 Hz),
4.24 (2H, q, J = 8.0 Hz), 4.38 (2
H, s), 4.70-4.88 (1H, m), 5.32.
(2H, bs), 6.94 (1H, d, J = 7.4H
z), 7.05 (1H, d, J = 8.8 Hz), 7.5
6 (1H, d, J = 5.2 Hz), 7.67 (1H, b
s), 8.80 (1H, s)

【0048】[0048]

【実施例4】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−エチルアミノ〕−3−メチルベン
ゾイル}−L−グルタミン酸(化合物2)の合成 実施例3の化合物(150mg)のエタノール(11m
l)溶液に1N−水酸化ナトリウム水溶液(0.84m
l)を加え35℃で4時間攪拌した。更に25℃で20
時間攪拌した後、反応液に水(1ml)を加え減圧下に
この反応液を乾固した。このとき、外温は30℃を越え
ないようにした。得られた黄色固形物を水(5ml)に
溶解し、1N−塩酸でpH=3.7に調整し冷蔵庫の中
で2時間放置した。析出した沈殿物を濾取し目的物(1
21mg)を得た。
Example 4 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-ethylamino] -3-methylben
Synthesis of Zoyl} -L-glutamic acid (Compound 2) Ethanol (11 m) of the compound of Example 3 (150 mg)
l) 1N-sodium hydroxide aqueous solution (0.84m
l) was added and the mixture was stirred at 35 ° C for 4 hours. 20 at 25 ° C
After stirring for an hour, water (1 ml) was added to the reaction solution, and the reaction solution was dried under reduced pressure. At this time, the external temperature did not exceed 30 ° C. The obtained yellow solid was dissolved in water (5 ml), adjusted to pH = 3.7 with 1N-hydrochloric acid, and left in a refrigerator for 2 hours. The deposited precipitate was collected by filtration and the desired product (1
21 mg).

【0049】H−NMR(CDCl,δ値):1.
04(3H,t,J=6.8Hz),1.85−2.2
8(2H,m),2.30−2.48(5H,m),
3.04(2H,q,J=6.8Hz),4.39(2
H,s),6.57(2H,bs),7.10(1H,
d,J=8.3Hz),7.61(1H,d,J=8.
3Hz),7.72(1H,s),8.34(1H,
d,J=7.8Hz),8.57(IH,s)
1 H-NMR (CDCl 3 , δ value):
04 (3H, t, J = 6.8 Hz), 1.85-2.2
8 (2H, m), 2.30-2.48 (5H, m),
3.04 (2H, q, J = 6.8 Hz), 4.39 (2
H, s), 6.57 (2H, bs), 7.10 (1H,
d, J = 8.3 Hz), 7.61 (1H, d, J = 8.
3Hz), 7.72 (1H, s), 8.34 (1H,
d, J = 7.8 Hz), 8.57 (IH, s)

【0050】[0050]

【参考例9】N−(N’−カルボベンゾキシ−N’−メチル−4−ア
ミノ−3−メチルベンゾイル)−L−2−アミノアジビ
ン酸ジメチルエステルの合成 参考例3の化合物(8.4g)を塩化チオニル(29m
l)に加えた後、さらに、触媒量のジメチルホルムアミ
ドを添加し室温にて2時間攪拌した。次いで反応液を減
圧下に濃縮乾固した。得られた固形物をジクロロメタン
(150ml)に溶解させ、この溶液にL−2−アミノ
アジピン酸ジメチルエステル塩酸塩(6.6g)、炭酸
カリウム(10g)を加え、さらに水(150ml)を
加え、室温にて激しく12時間攪拌した。反応液を水に
あけクロロホルムを用いて抽出し、1N−塩酸で洗浄
後、硫酸ナトリウムで乾燥した。溶媒を減圧下に留去し
た。得られた残渣をシリカゲルカラムクロマトグラフィ
ーに付し溶出溶媒としてクロロホルム:メタノール=1
00:3を用い目的物(9.7g)を得た。
Reference Example 9 N- (N'-carbobenzoxy-N'-methyl-4-a
Mino-3-methylbenzoyl) -L-2-aminoazibi
Synthesis of dimethyl acid ester The compound of Reference Example 3 (8.4 g) was converted to thionyl chloride (29 m
After adding to l), a catalytic amount of dimethylformamide was further added, and the mixture was stirred at room temperature for 2 hours. The reaction was then concentrated to dryness under reduced pressure. The obtained solid was dissolved in dichloromethane (150 ml), and L-2-aminoadipic acid dimethyl ester hydrochloride (6.6 g) and potassium carbonate (10 g) were added to the solution, and water (150 ml) was further added. Stirred vigorously at room temperature for 12 hours. The reaction solution was poured into water, extracted with chloroform, washed with 1N hydrochloric acid, and dried over sodium sulfate. The solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography, and chloroform: methanol = 1 as an elution solvent.
Using 00: 3, the desired product (9.7 g) was obtained.

【0051】H−NMR(CDCl,δ値):1.
45−2.55(9H,m),3.15(3H,s),
3.60(3H,s),3.72(3H,s),4.4
5−4.95(1H,m),5.05(2H,bs),
6.80−7.35(7H,m),7.45−7.95
(2H,m)
1 H-NMR (CDCl 3 , δ value):
45-2.55 (9H, m), 3.15 (3H, s),
3.60 (3H, s), 3.72 (3H, s), 4.4
5-4.95 (1H, m), 5.05 (2H, bs),
6.80-7.35 (7H, m), 7.45-7.95
(2H, m)

【0052】[0052]

【参考例10】N−〔N’−メチル−(4−アミノ−3−メチルベンゾ
イル)〕−L−2−アミノアジピン酸ジメチルエステル
の合成 アニソール(9.5g)を含む30%−臭化水素−酢酸
(100ml)溶液に参考例9の化合物(9.5g)を
加え室温にて4時間攪拌した。次に反応液に大量のエー
テルを加えたところ赤褐色の油状物質が沈殿した。大部
分のエーテル層を除き油状物質をクロロホルムに懸濁さ
せ、この懸濁液を飽和炭酸水素ナトリウム水溶液で洗浄
し、クロロホルムで抽出した。クロロホルム層を硫酸ナ
トリウムで乾燥し、減圧下に溶媒を留去し目的物(4.
0g)を得た。 H−NMR(CDCl,δ値):1.43−2.0
0(4H,m),2.03(3H,s),2.34(2
H,t,J=6Hz),2.90(3H,s),3.6
5(3H,s),3.75(3H,s),4.53−
5.03(1H,m),6.33−6.80(2H,
m),7.38−7.68(2H,m)
Reference Example 10 N- [N'-methyl- (4-amino-3-methylbenzo)
Yl)]-L-2-aminoadipate dimethyl ester
The compound of Reference Example 9 (9.5 g) was added to a 30% hydrogen bromide-acetic acid (100 ml) solution containing anisole (9.5 g), and the mixture was stirred at room temperature for 4 hours. Next, a large amount of ether was added to the reaction solution, and a red-brown oily substance precipitated. After removing most of the ether layer, the oily substance was suspended in chloroform, and the suspension was washed with a saturated aqueous solution of sodium hydrogen carbonate and extracted with chloroform. The chloroform layer was dried over sodium sulfate, and the solvent was distilled off under reduced pressure.
0 g). 1 H-NMR (CDCl 3 , δ value): 1.43-2.0
0 (4H, m), 2.03 (3H, s), 2.34 (2
H, t, J = 6 Hz), 2.90 (3H, s), 3.6
5 (3H, s), 3.75 (3H, s), 4.53-
5.03 (1H, m), 6.33-6.80 (2H,
m), 7.38-7.68 (2H, m)

【0053】[0053]

【実施例5】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−メチルアミノ〕−3−メチル}ベ
ンゾイル−L−2−アミノアジピン酸ジメチルエステル
の合成 参考例10の化合物(3.83g)と6−ブロモメチル
−2,4−ジアミノプテリジン臭化水素酸塩イソプロパ
ノール付加物(4.06g)をジメチルアセトアミド
(75ml)に懸濁し55−60℃で4時間攪拌した。
冷却後、反応液を飽和炭酸水素ナトリウム水溶液にあけ
クロロホルムで抽出した。クロロホルム層を硫酸ナトリ
ウムで乾燥後、溶媒を減圧にて留去し、得られた残渣を
シリカゲルクロマトグラフィーに付し、溶出溶媒として
クロロホルム:メタノール=10:1の混合溶媒を用い
目的物(3.41g)を得た。
Example 5 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-methyldibenzo
Nzoyl-L-2-aminoadipate dimethyl ester
The compound of Reference Example 10 (3.83 g) and 6-bromomethyl-2,4-diaminopteridine hydrobromide isopropanol adduct (4.06 g) were suspended in dimethylacetamide (75 ml) and the suspension was heated at 55-60 ° C. Stir for 4 hours.
After cooling, the reaction solution was poured into a saturated aqueous solution of sodium hydrogen carbonate and extracted with chloroform. After the chloroform layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography, using a mixed solvent of chloroform: methanol = 10: 1 as an elution solvent (3. 41 g) were obtained.

【0054】H−NMR(CDCl,δ値):1.
55−1.95(4H,m),2.26−2.46(5
H,m),2.74(3H,s),3.67(3H,
s),3.79(3H,s),4.33(2H,s),
4.70−4.85(1H,m),5.34(2H,b
s),6.78(1H,d,J=6.8Hz),7.0
5(1H,d,J=8.4Hz),7.61(1H,
d,J=7.8Hz),7.68(1H,s),8.8
5(1H,s)
1 H-NMR (CDCl 3 , δ value):
55-1.95 (4H, m), 2.26-2.46 (5
H, m), 2.74 (3H, s), 3.67 (3H,
s), 3.79 (3H, s), 4.33 (2H, s),
4.70-4.85 (1H, m), 5.34 (2H, b
s), 6.78 (1H, d, J = 6.8 Hz), 7.0
5 (1H, d, J = 8.4 Hz), 7.61 (1H,
d, J = 7.8 Hz), 7.68 (1H, s), 8.8
5 (1H, s)

【0055】[0055]

【実施例6】N−{4−[N’−(2,4−ジアミノ−
6−プテリジニル)メチル−N’−メチルアミノ]−3
−メチル}ベンゾイル−L−2−アミノアジピン酸(化
合物3)の合成 実施例5の化合物(3.0g)のエタノール(160m
l)溶液に1N−水酸化ナトリウム水溶液(18ml)
を加え35℃で4時間撹拌した。更に25℃で20時間
撹拌した後、反応液に水(20ml)を加え減圧下にこ
の反応液を乾固した。このとき外温は30℃を越えない
ようにした。得られた黄色固形物を水(50ml)に溶
解し、1N−塩酸でpH=3.7に調整し冷蔵庫の中で
2時間放置した。析出した沈殿物を濾取し、目的物
(2.3g)を得た。
Example 6 N- {4- [N '-(2,4-diamino-
6-pteridinyl) methyl-N'-methylamino] -3
-Methyldibenzoyl-L-2-aminoadipic acid
Synthesis of Compound 3) Ethanol (160 m) of the compound of Example 5 (3.0 g)
l) 1N aqueous solution of sodium hydroxide (18 ml)
Was added and stirred at 35 ° C. for 4 hours. After further stirring at 25 ° C. for 20 hours, water (20 ml) was added to the reaction solution, and the reaction solution was dried under reduced pressure. At this time, the external temperature was kept below 30 ° C. The obtained yellow solid was dissolved in water (50 ml), adjusted to pH = 3.7 with 1N-hydrochloric acid, and left in a refrigerator for 2 hours. The deposited precipitate was collected by filtration to obtain the desired product (2.3 g).

【0056】H−NMR(DMSO−d6,δ値):
1.40=1.88(4H,m),2.24(2H,
t,J=7.8Hz),2.41(3H,s),2.7
2(3H,s),4.23−4.43(4H,m),
6.64(2H,bs),7.11(1H,d,J=
8.8Hz),7.66(1H,d,J=8.3H
z),7.74(1H,s),8.38(1H,d,J
=8.2Hz),8.64(1H,s)
1 H-NMR (DMSO-d6, δ value):
1.40 = 1.88 (4H, m), 2.24 (2H,
t, J = 7.8 Hz), 2.41 (3H, s), 2.7
2 (3H, s), 4.23-4.43 (4H, m),
6.64 (2H, bs), 7.11 (1H, d, J =
8.8 Hz), 7.66 (1H, d, J = 8.3H)
z), 7.74 (1H, s), 8.38 (1H, d, J
= 8.2Hz), 8.64 (1H, s)

【0057】[0057]

【参考例11】4−2,4−〔N’−(ジアミノ−6−プテリジニル)
メチル〕−N’−メチルアミノ−3−メチル安息香酸の
合成 窒素雰囲気下6−ブロモメチル−2,4−ジアミノプテ
リジン臭化水素酸塩イソプロパノール付加物(3.8
g)と、4−メチルアミノ−3−メチル安息香酸(4.
8g)をジメチルアセトアミド(50ml)に懸濁さ
せ、40℃で4日間攪拌した後、55℃で2時間攪拌し
た。反応を水(500ml)にあけ、1N−水酸化ナト
リウム水溶液でpH=5に調整し、生じた沈殿を濾取
し、水、アセトンで洗浄することにより目的物(3.3
g)を得た。 H−NMR(DMSO−d6,δ値):2.40(3
H,s),2.74(3H,s),4.36(2H,
s),7.10(1H,d,J=8.3Hz),7.6
−7.8(2H,m),8.64(1H,s)
Reference Example 11 4-2,4- [N '-(diamino-6-pteridinyl)
Methyl] -N'-methylamino-3-methylbenzoic acid
Under a synthetic nitrogen atmosphere, 6-bromomethyl-2,4-diaminopteridine hydrobromide isopropanol adduct (3.8
g) and 4-methylamino-3-methylbenzoic acid (4.
8 g) was suspended in dimethylacetamide (50 ml), stirred at 40 ° C. for 4 days, and then stirred at 55 ° C. for 2 hours. The reaction was poured into water (500 ml), the pH was adjusted to 5 with a 1N aqueous solution of sodium hydroxide, and the resulting precipitate was collected by filtration and washed with water and acetone to obtain the desired product (3.3).
g) was obtained. 1 H-NMR (DMSO-d6, δ value): 2.40 (3
H, s), 2.74 (3H, s), 4.36 (2H,
s), 7.10 (1H, d, J = 8.3 Hz), 7.6
-7.8 (2H, m), 8.64 (1H, s)

【0058】[0058]

【実施例7】N−{4−〔N’−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N’−メチルアミノ〕−3−メチル}ベ
ンゾイル−L−ホモシステイン酸アンモニウム塩の合成 窒素雰囲気下参考例11の化合物(2.4g)のジメチ
ルアセトアミド(250ml)懸濁液に、0℃でトリエ
チルアミン(2.7ml)とクロルギ酸イソブチル
(0.85ml)とを加え、5分間撹拌後、更にクロル
ギ酸イソブチル(0.12ml)を加え5分間撹拌し
た。この溶液にL−ホモシステイン酸メチルエステル塩
酸塩(1.5g)を加え30分間撹拌した後トリエチル
アミン(1.35ml)、クロルギ酸イソブチル(0.
42ml)、L−ホモシステイン酸メチル塩酸塩(0.
75g)を同様に加え30分間撹拌した。徐々に室温ま
で昇温し、45分間撹拌した後、浴温が40℃をこえな
いように減圧下溶媒を留去し、残渣に0.1N−水酸化
ナトリウム水溶液(400ml)を加え室温で2時間撹
拌した後、更に1N−水酸化ナトリウム水溶液(8m
l)を加え20分間撹拌した。反応液を凍結乾燥し、得
られた残渣をシリカゲルカラムクロマトグラフィーに付
し、溶出溶媒としてクロロホルム:メタノール:アンモ
ニア水=5:4:1を用い溶出し、得られた粗生成物を
さらにDEAEセルロースカラムに付し、水で洗浄した
後、3%重炭酸アンモニウム水溶液で溶出し目的物
(1.1g)を得た。
Example 7 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-methyldibenzo
Synthesis of ammonium salt of nzoyl-L-homocysteic acid Under a nitrogen atmosphere, a suspension of the compound of Reference Example 11 (2.4 g) in dimethylacetamide (250 ml) was added at 0 ° C. with triethylamine (2.7 ml) and isobutyl chloroformate (0 ml). .85 ml) and stirred for 5 minutes, and then isobutyl chloroformate (0.12 ml) was further added and stirred for 5 minutes. To this solution was added L-homocysteic acid methyl ester hydrochloride (1.5 g), and the mixture was stirred for 30 minutes. Then, triethylamine (1.35 ml) and isobutyl chloroformate (0.3 g) were added.
42 ml), methyl L-homocysteate hydrochloride (0.
75 g) was added in the same manner and stirred for 30 minutes. After gradually raising the temperature to room temperature and stirring for 45 minutes, the solvent was distilled off under reduced pressure so that the bath temperature did not exceed 40 ° C., and a 0.1N aqueous sodium hydroxide solution (400 ml) was added to the residue, and the mixture was stirred at room temperature for 2 minutes. After stirring for an hour, a 1N aqueous sodium hydroxide solution (8 m
l) was added and stirred for 20 minutes. The reaction solution was freeze-dried, the obtained residue was subjected to silica gel column chromatography, and eluted with chloroform: methanol: aqueous ammonia = 5: 4: 1 as an elution solvent, and the obtained crude product was further subjected to DEAE cellulose. The mixture was applied to a column, washed with water, and eluted with a 3% aqueous solution of ammonium bicarbonate to obtain the desired product (1.1 g).

【0059】H−NMR(DO,δ値):2.15
−2.25(1H,m),2.3−2.4(1H,
m),2.4(3H,s),2.8(3H,s),2.
9−3.1(2H,m),4.4−4.5(1H,
m),4.5(2H,s)7.1(1H,d,J=8.
5Hz),7.6(1H,d,J=8.5Hz),7.
7(1H,m),8.6(1H,s)
1 H-NMR (D 2 O, δ value): 2.15
-2.25 (1H, m), 2.3-2.4 (1H,
m), 2.4 (3H, s), 2.8 (3H, s), 2.
9-3.1 (2H, m), 4.4-4.5 (1H,
m), 4.5 (2H, s) 7.1 (1H, d, J = 8.
5 Hz), 7.6 (1H, d, J = 8.5 Hz), 7.
7 (1H, m), 8.6 (1H, s)

【0060】[0060]

【参考例12】N−p−トルエンスルホニル−4−アミノ−3−エチル
安息香酸メチルエステルの合成 3−エチル−4−アミノ安息香酸メチルエステル(1.
86g)のピリジン(30ml)溶液に、p−トルエン
スルホニルクロライド(3g)を加え、室温にて3時間
撹拌した。反応後減圧下に溶媒を留去し、残渣にクロロ
ホルムと1N−塩酸を加え撹拌した後、有機層を分取し
た。有機層を硫酸マグネシウムで乾燥後、減圧で溶媒を
留去し、得られた残渣をシリカゲルクロマトグラフィー
に付し、溶出溶媒としてヘキサン:酢酸エチル4:1の
混合溶媒を用いて目的物(3g)を得た。
Reference Example 12 Np-toluenesulfonyl-4-amino-3-ethyl
Synthesis of benzoic acid methyl ester 3-ethyl-4-aminobenzoic acid methyl ester (1.
To a solution of 86 g) in pyridine (30 ml) was added p-toluenesulfonyl chloride (3 g), and the mixture was stirred at room temperature for 3 hours. After the reaction, the solvent was distilled off under reduced pressure, chloroform and 1N-hydrochloric acid were added to the residue, and the mixture was stirred, and then the organic layer was separated. After the organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was subjected to silica gel chromatography, using a mixed solvent of hexane: ethyl acetate 4: 1 as an elution solvent (3 g). I got

【0061】H−NMR(CDCl,δ値):1.
10(3H,t),2.40(3H,s),2.1−
2.6(2H,m),3.90(3H,s),6.6−
7.9(7H,m)
1 H-NMR (CDCl 3 , δ value): 1.
10 (3H, t), 2.40 (3H, s), 2.1-
2.6 (2H, m), 3.90 (3H, s), 6.6
7.9 (7H, m)

【0062】[0062]

【参考例13】N−p−トルエンスルホニル−N−メチル−4−アミノ
−3−エチル安息香酸メチルエステルの合成 参考例12の化合物(3g)の無水ジメチルホルムアミ
ド(50ml)溶液に、氷冷下水素化ナトリウム(1.
3g)を加え、10分間室温で撹拌した。次いでこの反
応液にヨウ化メチル(3.8g)を加え、室温に戻した
後2時間撹拌した。反応後、この反応液に水を加え、酢
酸エチルで抽出した。酢酸エチル層を硫酸マグネシウム
で乾燥した後、減圧下にて溶媒を留去し、得られた残渣
をシリカゲルカラムクロマトグラフィーに付し、溶出溶
媒としてクロロホルムを用いて目的物(1.56g)を
得た。
Reference Example 13 Np-toluenesulfonyl-N-methyl-4-amino
Synthesis of methyl 3-ethylbenzoate In a solution of the compound of Reference Example 12 (3 g) in anhydrous dimethylformamide (50 ml) was added sodium hydride (1.
3g) was added and stirred at room temperature for 10 minutes. Then, methyl iodide (3.8 g) was added to the reaction solution, and the mixture was returned to room temperature and stirred for 2 hours. After the reaction, water was added to the reaction solution, and extracted with ethyl acetate. After the ethyl acetate layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel column chromatography to obtain the desired product (1.56 g) using chloroform as an elution solvent. Was.

【0063】H−NMR(CDCl,δ値):1.
25(3H,t),2.45(3H,s),2.7−
3.1(2H,m)3.15(3H,s),3.90
(3H,s),6.6−8.1(7H,m)
1 H-NMR (CDCl 3 , δ value):
25 (3H, t), 2.45 (3H, s), 2.7-
3.1 (2H, m) 3.15 (3H, s), 3.90
(3H, s), 6.6-8.1 (7H, m)

【0064】[0064]

【参考例14】N−p−トルエンスルホニル−N−メチル−4−アミノ
−3−エチル安息香酸の合成 参考例13の化合物(1.56g)のメタノール(60
ml)溶液に、1N水酸化ナトリウム水溶液(60m
l)を加え、還流させながら2時間撹拌した。水浴の温
度を30℃以下に保ちながら、減圧下で溶媒を濃縮し
た。この反応液に1N−塩酸を加えpH=2.5に調整
し、析出した沈澱物を濾取し、目的物(1.33g)を
得た。
Reference Example 14 Np-toluenesulfonyl-N-methyl-4-amino
Synthesis of -3-ethylbenzoic acid The compound (1.56 g) of Reference Example 13 in methanol (60
ml) solution, 1N aqueous sodium hydroxide solution (60 m
l) was added, and the mixture was stirred under reflux for 2 hours. The solvent was concentrated under reduced pressure while maintaining the temperature of the water bath at 30 ° C. or lower. 1N-hydrochloric acid was added to the reaction solution to adjust the pH to 2.5, and the deposited precipitate was collected by filtration to obtain the desired product (1.33 g).

【0065】H−NMR(CDCl,δ値):1.
25(3H,t),2.45(3H,s),2.7−
3.1(2H,m),3.15(3H,s),6.6−
8.2(7H,m)
1 H-NMR (CDCl 3 , δ value):
25 (3H, t), 2.45 (3H, s), 2.7-
3.1 (2H, m), 3.15 (3H, s), 6.6
8.2 (7H, m)

【0066】[0066]

【参考例15】N−(N′−ロートルエンスルホニル−N′−メチル−
4−アミノ−3−エチルベンゾイル)−L−グルタミン
酸ジエチルエステルの合成 参考例14の化合物(1.33g)を塩化チオニル(5
ml)に加えた後、更に触媒量のジメチルホルムアミド
を添加し、室温にて2時間撹拌した。次に反応液を減圧
下にて濃縮乾固した。得られた固形物をジクロロメタン
(35ml)に溶解させ、この溶液にグルタミン酸ジエ
チルエステル塩酸塩(900mg)、炭酸カリウム
(1.4g)を加え、さらに水(15ml)を加え、室
温にて激しく一夜撹拌した。反応液を水にあけ、クロロ
ホルムで抽出した後、クロロホルム層を飽和炭酸水素ナ
トリウム水溶液、1N−塩酸で洗浄し、硫酸マグネシウ
ムで乾燥した。溶媒を減圧下にて留去し、目的物(1.
5g)を得た。
[Reference Example 15] N- (N'-lawtoluenesulfonyl-N'-methyl-
4-amino-3-ethylbenzoyl) -L-glutamine
Synthesis of diethyl acid ester The compound of Reference Example 14 (1.33 g) was converted to thionyl chloride (5
ml), a catalytic amount of dimethylformamide was further added, and the mixture was stirred at room temperature for 2 hours. Next, the reaction solution was concentrated to dryness under reduced pressure. The obtained solid was dissolved in dichloromethane (35 ml), and glutamic acid diethyl ester hydrochloride (900 mg) and potassium carbonate (1.4 g) were added to the solution. Water (15 ml) was further added, followed by vigorous stirring at room temperature overnight. did. After the reaction solution was poured into water and extracted with chloroform, the chloroform layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, 1N-hydrochloric acid, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the target compound (1.
5 g) were obtained.

【0067】H−NMR(CDCl,δ値):1.
0−1.4(9H,m),2.0−3.0(6H,
m),2.45(3H,s),3,10(3H,s),
3.9−4.4(4H,m),4.5−5.0(1H,
m),6.5−7.9(7H,m)
1 H-NMR (CDCl 3 , δ value): 1.
0-1.4 (9H, m), 2.0-3.0 (6H,
m), 2.45 (3H, s), 3, 10 (3H, s),
3.9-4.4 (4H, m), 4.5-5.0 (1H,
m), 6.5-7.9 (7H, m)

【0068】[0068]

【参考例16】 N−(N’−メチル−4−アミノ−3−エチルベンゾイ
ル)−L−グルタミン酸ジエチルエステルの合成
[Reference Example 16] N-(N'-methyl-4-amino-3-ethyl-benzoyl) -L- synthesis of glutamic acid diethyl ester

【0069】アニソール(1.5g)の30%臭化水素
−酢酸(15ml)溶液に参考例15化合物(1.5
g)を加え、室温にて4.5時間撹拌した。次に反応液
にエーテル(300ml)を加えたところ赤褐色の油状
物質が沈澱した。大部分のエーテル層を除き、油状物質
をクロロホルムに懸濁させ、次いでこの懸濁液を飽和炭
酸水素ナトリウム水溶液で洗浄した後、有機層を分取し
た。有機層を硫酸マグネシウムで乾燥し、減圧下にて溶
媒を留去し、目的物(1.0g)を得た。
To a solution of anisole (1.5 g) in 30% hydrogen bromide-acetic acid (15 ml) was added the compound of Reference Example 15 (1.5 g).
g) was added and the mixture was stirred at room temperature for 4.5 hours. Next, ether (300 ml) was added to the reaction solution, and a red-brown oily substance precipitated. After removing most of the ether layer, the oily substance was suspended in chloroform. The suspension was washed with a saturated aqueous solution of sodium hydrogen carbonate, and the organic layer was separated. The organic layer was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product (1.0 g).

【0070】H−NMR(CDCl,δ値):1.
0−1.4(9H,m),2.0−3.0(6H,
m),2.85(3H,s),3.7−4.3(4H,
m),4.5−4.9(1H,m),6.4−7.7
(3H,m)
1 H-NMR (CDCl 3 , δ value):
0-1.4 (9H, m), 2.0-3.0 (6H,
m), 2.85 (3H, s), 3.7-4.3 (4H,
m), 4.5-4.9 (1H, m), 6.4-7.7
(3H, m)

【0071】[0071]

【実施例8】N−{4−〔N′−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N′−メチルアミノ〕−3−エチルベン
ゾイル}−L−グルタミン酸ジエチルエステルの合成
Example 8 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-ethylben
Synthesis of Zoyl} -L-glutamic acid diethyl ester

【0072】参考例16の化合物(1.0g)と6−ブ
ロモメチル−2,4−ジアミノプテリジン臭化水素酸塩
・イソプロパノール付加物(1.1g)をジメチルアセ
トアミド(10ml)に懸濁させ、60℃で6時間撹拌
した。冷却後、反応液を飽和炭酸水素ナトリウム水溶液
にあけ、クロロホルムで抽出した。有機層を硫酸マグネ
シウムで乾燥後、溶媒を減圧下で留去した。得られた残
渣をシリカゲルカラムクロマトグラフィーに付し、溶出
溶媒としてクロロホルム:メタノール=10:1の混合
溶媒を用い目的物(671mg)を得た。
The compound of Reference Example 16 (1.0 g) and 6-bromomethyl-2,4-diaminopteridine hydrobromide / isopropanol adduct (1.1 g) were suspended in dimethylacetamide (10 ml). Stirred at C for 6 hours. After cooling, the reaction solution was poured into a saturated aqueous solution of sodium hydrogen carbonate and extracted with chloroform. After the organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography, and the desired product (671 mg) was obtained using a mixed solvent of chloroform: methanol = 10: 1 as an elution solvent.

【0073】H−NMR(CDOD,δ値):1.
0−1.4(9H,m),2.0−3.0(6H,
m),2.75(3H,s),3.9−4.7(7H,
m),7.1−7.8(3H,m),8.70(1H,
s)
1 H-NMR (CD 3 OD, δ value):
0-1.4 (9H, m), 2.0-3.0 (6H,
m), 2.75 (3H, s), 3.9-4.7 (7H,
m), 7.1-7.8 (3H, m), 8.70 (1H,
s)

【0074】[0074]

【実施例9】N−{4−〔N′−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N′−メチルアミノ〕−3−エチルベン
ゾイル}−L−グルタミン酸(化合物4)の合成
Example 9 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3-ethylben
Synthesis of Zoyl} -L-glutamic acid (Compound 4)

【0075】実施例8の化合物(640mg)のエタノ
ール(22ml)溶液に、1N−水酸化ナトリウム水溶
液(1.78ml)を加え、35℃で4.5時間撹拌し
た。更に25℃で20時間撹拌を続けた後、反応液に水
(2ml)を加え、次いで水−氷冷下、反応液を1N−
塩酸でpH=3.7に調整し、冷所で一夜放置した。析
出した沈澱物を濾取し、目的物(340mg)を得た。
To a solution of the compound of Example 8 (640 mg) in ethanol (22 ml) was added a 1N aqueous solution of sodium hydroxide (1.78 ml), and the mixture was stirred at 35 ° C. for 4.5 hours. After further stirring at 25 ° C. for 20 hours, water (2 ml) was added to the reaction mixture, and then the reaction mixture was cooled with 1N-water under ice-cooling.
The pH was adjusted to 3.7 with hydrochloric acid, and the mixture was left overnight in a cool place. The deposited precipitate was collected by filtration to obtain the desired product (340 mg).

【0076】H−NMR(DMSO−d6,δ値):
1.26(3H,m),1.9−2.5(4H,m),
2.69(3H,s),2.80(2H,m),4.2
9(2H,s),4.39(1H,m),7.22(1
H,m),7.71(2H,m),8.64(1H,
s)
1 H-NMR (DMSO-d6, δ value):
1.26 (3H, m), 1.9-2.5 (4H, m),
2.69 (3H, s), 2.80 (2H, m), 4.2
9 (2H, s), 4.39 (1H, m), 7.22 (1
H, m), 7.71 (2H, m), 8.64 (1H,
s)

【0077】[0077]

【参考例17】N−カルボベンゾキシ−4−アミノ−3,5−ジメチル
安息香酸エチルエステルの合成
[Reference Example 17] N-carbobenzoxy-4-amino-3,5-dimethyl
Synthesis of ethyl benzoate

【0078】窒素雰囲気下水素化ナトリウム(0.82
g)のテトラヒドロフラン(THF)懸濁液中に、4−
アミノ−3,5−ジメチル安息香酸エチルエステル
(2.0g)を加え、室温で30分間撹拌した。次いで
懸濁液にカルボベンゾキシクロライド(4.4ml)を
加え、一夜撹拌した。反応液に少量の水を加えた後、氷
水中にあけ、酢酸エチルで抽出した。水洗、乾燥(硫酸
マグネシウム)後、減圧下に溶媒を留去した。析出した
結晶をエタノールを加えて濾取し、真空乾燥した後、目
的物(3.2g)を得た。
Under a nitrogen atmosphere, sodium hydride (0.82
g) in tetrahydrofuran (THF) suspension
Amino-3,5-dimethylbenzoic acid ethyl ester (2.0 g) was added, and the mixture was stirred at room temperature for 30 minutes. Then, carbobenzoxychloride (4.4 ml) was added to the suspension, and the mixture was stirred overnight. After a small amount of water was added to the reaction solution, it was poured into ice water and extracted with ethyl acetate. After washing with water and drying (magnesium sulfate), the solvent was distilled off under reduced pressure. The precipitated crystals were added with ethanol, collected by filtration, and dried in vacuo to obtain the desired product (3.2 g).

【0079】H−NMR(CDCl,δ値):1.
39(3H,t,J=7Hz),2.05(6H,
s),4.35(2H,q,J=7Hz),5.15
(2H,s),7.23(5H,m),7.75(2
H,s)
1 H-NMR (CDCl 3 , δ value): 1.
39 (3H, t, J = 7 Hz), 2.05 (6H,
s), 4.35 (2H, q, J = 7 Hz), 5.15
(2H, s), 7.23 (5H, m), 7.75 (2
H, s)

【0080】[0080]

【参考例18】N−カルボベンゾキシ−N−メチル−4−アミノ−3,
5−ジメチル安息香酸エチルエステルの合成
Reference Example 18 N-carbobenzoxy-N-methyl-4-amino-3,
Synthesis of 5-dimethylbenzoic acid ethyl ester

【0081】窒素雰囲気下水素化ナトリウム(1.2
g)をジメチルホルムアミド(50ml)に懸濁させ撹
拌した。懸濁液に参考例17の化合物(3.2g)を室
温で加え、30分間撹拌した後にヨウ化メチル(1.8
ml)を加え、さらに室温で一夜撹拌した。次いで数滴
の水を氷冷下反応液に加え、反応液を氷水中にあけた。
酢酸エチルを用いて抽出し、硫酸マグネシウムで乾燥し
た。減圧下に溶媒を留去し、得られた残渣をシリカゲル
カラムクロマトグラフィーに付し、溶出溶媒としてヘキ
サン:酢酸エチル=9:1を用い目的物(1.47g)
を得た。
Under a nitrogen atmosphere, sodium hydride (1.2
g) was suspended in dimethylformamide (50 ml) and stirred. The compound of Reference Example 17 (3.2 g) was added to the suspension at room temperature, and the mixture was stirred for 30 minutes and then methyl iodide (1.8).
ml), and the mixture was further stirred at room temperature overnight. Next, a few drops of water were added to the reaction solution under ice cooling, and the reaction solution was poured into ice water.
Extracted with ethyl acetate and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel column chromatography, and using hexane: ethyl acetate = 9: 1 as an eluting solvent, the desired product (1.47 g).
I got

【0082】H−NMR(CDCl,δ値):1.
38(3H,t,J=7Hz),2.21(6H,
s),3.17(3H,s),4.42(2H,q,J
=7Hz),5.13(2H,s),7.0−7.6,
(5H,m),7.80(2H,s)
1 H-NMR (CDCl 3 , δ value):
38 (3H, t, J = 7 Hz), 2.21 (6H,
s), 3.17 (3H, s), 4.42 (2H, q, J
= 7 Hz), 5.13 (2H, s), 7.0-7.6,
(5H, m), 7.80 (2H, s)

【0083】[0083]

【参考例19】N−カルボベンゾキシ−N−メチル−4−アミノ−3,
5−ジメチル安息香酸の合成
Reference Example 19 N-carbobenzoxy-N-methyl-4-amino-3,
Synthesis of 5-dimethylbenzoic acid

【0084】参考例18の化合物(1.47g)のTH
F(30ml)溶液に1N−水酸化ナトリウム水溶液
(12ml)を加え、60℃で6時間加熱し、更に室温
で一夜撹拌した。次いで反応液を3N−塩酸でpHを約
5とし、減圧下に濃縮した。pHを約2とした後THF
を用いて抽出し、硫酸マグネシウムで乾燥した。溶媒を
減圧下に留去し目的物(1.34g)を得た。
TH of the compound of Reference Example 18 (1.47 g)
A 1N aqueous solution of sodium hydroxide (12 ml) was added to the F (30 ml) solution, the mixture was heated at 60 ° C. for 6 hours, and further stirred at room temperature overnight. Then, the pH of the reaction solution was adjusted to about 5 with 3N-hydrochloric acid, and the mixture was concentrated under reduced pressure. After adjusting the pH to about 2, THF
And dried over magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the desired product (1.34 g).

【0085】H−NMR(CDCl,δ値):2.
18(6H,s),3.14(3H,s),5.04
(2H,s),6.9−7.5(5H,m),7.76
(2H,s)
1 H-NMR (CDCl 3 , δ value):
18 (6H, s), 3.14 (3H, s), 5.04
(2H, s), 6.9-7.5 (5H, m), 7.76
(2H, s)

【0086】[0086]

【参考例20】N−(N′−カルボベンゾキシ−N′−メチル−4−ア
ミノ−3,5−ジメチルベンゾイル)−L−グルタミン
酸ジエチルエステルの合成
Reference Example 20 N- (N'-carbobenzoxy-N'-methyl-4-a
Mino-3,5-dimethylbenzoyl) -L-glutamine
Of diethyl methacrylate

【0087】参考例19の化合物(1.34g)を塩化
チオニル(10ml)を加えた後、更に触媒量のジメチ
ルホルムアミドを添加し室温にて3時間撹拌した。次に
反応液を減圧下に濃縮乾固した。得られた固形物をジク
ロロメタン(25ml)に溶解させ、この溶液にグルタ
ミン酸ジエチルエステル塩酸塩(1.0g)の水溶液
(25ml)と炭酸カリウム(1.2g)を加え、さら
に炭酸カリウムを用い反応液のpHを約10とした後、
室温にて激しく一夜撹拌した。ジクロロメタン層を分取
し、1N−塩酸、飽和炭酸水素ナトリウム水溶液、飽和
食塩水の順で洗浄し、硫酸ナトリウムで乾燥した。溶媒
を減圧下に留去し、目的物(2.14g)を得た。
To the compound of Reference Example 19 (1.34 g) was added thionyl chloride (10 ml), and a catalytic amount of dimethylformamide was further added, followed by stirring at room temperature for 3 hours. Next, the reaction solution was concentrated to dryness under reduced pressure. The obtained solid was dissolved in dichloromethane (25 ml), and an aqueous solution (25 ml) of glutamic acid diethyl ester hydrochloride (1.0 g) and potassium carbonate (1.2 g) were added to the solution. After adjusting the pH of the solution to about 10,
Stir vigorously overnight at room temperature. The dichloromethane layer was separated, washed with 1N-hydrochloric acid, a saturated aqueous solution of sodium hydrogen carbonate and saturated saline in this order, and dried over sodium sulfate. The solvent was distilled off under reduced pressure to obtain the desired product (2.14 g).

【0088】H−NMR(CDCl,δ値):1.
23(3H,t,J=7Hz),1.31(3H,t,
J=7Hz),2.1−2.7(4H,m),2.17
(6H,s),3.13(3H,s),4.13(2
H,q,J=7Hz),4.25(2H,q,J=7H
z),4.73(1H,m),5.07(2H,s),
6.94(1H,d,J=8Hz),7.1−7.5
(5H,m),7.51(2H,s)
1 H-NMR (CDCl 3 , δ value): 1.
23 (3H, t, J = 7 Hz), 1.31 (3H, t,
J = 7 Hz), 2.1-2.7 (4H, m), 2.17
(6H, s), 3.13 (3H, s), 4.13 (2
H, q, J = 7 Hz), 4.25 (2H, q, J = 7H)
z), 4.73 (1H, m), 5.07 (2H, s),
6.94 (1H, d, J = 8 Hz), 7.1-7.5
(5H, m), 7.51 (2H, s)

【0089】[0089]

【参考例21】 N−〔N′−メチル−(4−アミノ−3,5−ジメチル
ベンゾイル)〕−L−グルタミン酸ジエチルエステルの
合成
Reference Example 21 N- [N'-methyl- (4-amino-3,5-dimethylbenzoyl)]-L- glutamic acid diethyl ester
Synthesis

【0090】参考例20の化合物(2.1g)のアニソ
ール(2.4ml)溶液に、30%−臭化水素−酢酸
(24ml)溶液を加え室温にて3時間撹拌した。次に
反応液に約200mlのエーテルを加えたところ赤褐色
の油状物質が沈澱した。大部分のエーテル層を除き油状
物質をクロロホルムに懸濁させ、この懸濁液を飽和炭酸
水素ナトリウム水溶液で洗浄し、有機層を分取した。有
機層を硫酸ナトリウムで乾燥した後、減圧下に溶媒を留
去し目的物(1.2g)を得た。
To a solution of the compound of Reference Example 20 (2.1 g) in anisole (2.4 ml) was added a 30% hydrogen bromide-acetic acid (24 ml) solution, and the mixture was stirred at room temperature for 3 hours. Next, about 200 ml of ether was added to the reaction solution, and a red-brown oily substance precipitated. After removing most of the ether layer, the oily substance was suspended in chloroform. This suspension was washed with a saturated aqueous solution of sodium hydrogen carbonate, and the organic layer was separated. After the organic layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure to obtain the desired product (1.2 g).

【0091】H−NMR(CDCl,δ値):1.
21(3H,t,J=7Hz),1.29(3H,t,
J=7Hz),2.0−2.8(4H,m),2.29
(6H,s),2.87(3H,s),3.11(1
H,s),4.11(2H,q,J=7Hz),4.2
3(2H,q,J=7Hz),4.83(1H,m),
6.83(1H,d,J=8Hz),7.43(2H,
s)
1 H-NMR (CDCl 3 , δ value): 1.
21 (3H, t, J = 7 Hz), 1.29 (3H, t,
J = 7 Hz), 2.0-2.8 (4H, m), 2.29
(6H, s), 2.87 (3H, s), 3.11 (1
H, s), 4.11 (2H, q, J = 7 Hz), 4.2
3 (2H, q, J = 7 Hz), 4.83 (1H, m),
6.83 (1H, d, J = 8 Hz), 7.43 (2H,
s)

【0092】[0092]

【実施例10】N−{4−〔N′−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N′−メチルアミノ〕−3,5−ジメチ
ルベンゾイル}−L−グルタミン酸ジエチルエステルの
合成
Example 10 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3,5-dimethyl
Of rubenzoyl} -L-glutamic acid diethyl ester
Synthesis

【0093】参考例21の化合物(1.2g)と6−ブ
ロモメチル−2,4−ジアミノプテリジン臭化水素酸塩
イソプロパノール付加物(1.0g)をジメチルアセト
アミド(20ml)に懸濁し、60℃で12時間撹拌し
た。冷却後、反応液に水を加え撹拌し、次にクロロホル
ムで抽出した。クロロホルム層を硫酸ナトリウムで乾燥
後、溶媒を減圧下に留去し、得られた残渣をシリカゲル
クロマトグラフィーに付し、溶出溶媒としてクロロホル
ムメタノール=99:1〜95:5の混合溶媒を用い目
的物(0.64g)を得た。
The compound of Reference Example 21 (1.2 g) and 6-bromomethyl-2,4-diaminopteridine hydrobromide isopropanol adduct (1.0 g) were suspended in dimethylacetamide (20 ml). Stir for 12 hours. After cooling, water was added to the reaction solution, the mixture was stirred, and then extracted with chloroform. After the chloroform layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure, and the obtained residue was subjected to silica gel chromatography, using a mixed solvent of chloroform methanol = 99: 1 to 95: 5 as an elution solvent. (0.64 g).

【0094】H−NMR(CDCl,+CD
D,δ値):1.25(3H,t,J=7Hz),1.
32(3H,t,J=7Hz),2.0−2.7(4
H,m),2.42(6H,s),2.82(3H,
s),4.18(2H,q,J=7Hz),4.28
(2H,q,J=7Hz),4.42(2H,s),
4.78(1H,m),7.53(2H,s),8.8
9(1H,s)
1 H-NMR (CDCl 3 , + CD 3 O
D, δ value): 1.25 (3H, t, J = 7 Hz);
32 (3H, t, J = 7 Hz), 2.0-2.7 (4
H, m), 2.42 (6H, s), 2.82 (3H,
s), 4.18 (2H, q, J = 7 Hz), 4.28
(2H, q, J = 7 Hz), 4.42 (2H, s),
4.78 (1H, m), 7.53 (2H, s), 8.8
9 (1H, s)

【0095】[0095]

【実施例11】N−{4−〔N′−(2,4−ジアミノ−6−プテリジ
ニル)メチル−N′−メチルアミノ〕−3,5−ジメチ
ルベンゾイル}−L−グルタミン酸(化合物5)の合成
Example 11 N- {4- [N '-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methylamino] -3,5-dimethyl
Synthesis of Rubenzoyl} -L-glutamic acid (Compound 5)

【0096】実施例10の化合物(0.59g)をエタ
ノール(40ml)とTHF(20ml)の混合溶媒に
溶解し、さらに1N−水酸化ナトリウム水溶液(3.5
ml)を加え室温で一夜撹拌した。減圧下に溶媒を留去
し、得られた黄色固形物を水(20ml)に溶解し、氷
冷下1N−塩酸でpH=3.7に調整し、析出した沈殿
物を濾取した。水、アセトンの順で洗浄後、真空乾燥し
て目的物(0.47g)を得た。
The compound of Example 10 (0.59 g) was dissolved in a mixed solvent of ethanol (40 ml) and THF (20 ml), and further dissolved in a 1N aqueous sodium hydroxide solution (3.5.
ml) and the mixture was stirred at room temperature overnight. The solvent was distilled off under reduced pressure, and the obtained yellow solid was dissolved in water (20 ml), adjusted to pH = 3.7 with 1N hydrochloric acid under ice cooling, and the deposited precipitate was collected by filtration. After washing in order of water and acetone, vacuum drying was performed to obtain the desired product (0.47 g).

【0097】H−NMR(DMSO−d,δ値):
1.8−2.2(2H,m),2.3−2.5(2H,
m),2.34(6H,s),2.73(3H,s),
4.3−4.5(1H,m),4.36(2H,s),
6.66(2H,s),7.55(2H,s),8.4
0(1H,d,J=6Hz),8.74(1H,s)
1 H-NMR (DMSO-d 6 , δ value):
1.8-2.2 (2H, m), 2.3-2.5 (2H,
m), 2.34 (6H, s), 2.73 (3H, s),
4.3-4.5 (1H, m), 4.36 (2H, s),
6.66 (2H, s), 7.55 (2H, s), 8.4
0 (1H, d, J = 6 Hz), 8.74 (1H, s)

【0098】[0098]

【参考例22】4−メチルアミノ−3−トリフルオロメチル安息香酸の
合成 4−アミノ−3−トリフルオロメチル安息香酸(3.6
g)を無水トリフルオロ酢酸(90ml)に懸濁し、一
晩攪拌した。減圧下で溶媒を留去し、得られた残渣をア
セトン(30ml)に溶解した。この溶液にヨウ化メチ
ル(9.9g)を加え、45℃に加熱し、激しく撹拌し
ながら粉末水酸化カリウム(6.8g)を徐々に加え
た。この温度でさらに1時間攪拌を続けた後、減圧下で
溶媒を留去した。得られた残渣を水(50ml)に溶解
し、2時間加熱還流した。氷冷下、1N−塩酸を用い
て、pH=3.5に調節した。白色沈殿物を濾取し、少
量の水で洗浄した後、真空乾燥し目的物(2.2g)を
得た。 H−NMR(CDCl:CDOD=1:1,δ
値):2.95(3H,s),6.74(1H,d,J
=9.0Hz),7.96−8.12(2H,m)
Reference Example 22 of 4-methylamino-3-trifluoromethylbenzoic acid
Synthetic 4-amino-3-trifluoromethylbenzoic acid (3.6
g) was suspended in trifluoroacetic anhydride (90 ml) and stirred overnight. The solvent was distilled off under reduced pressure, and the obtained residue was dissolved in acetone (30 ml). To this solution was added methyl iodide (9.9 g), heated to 45 ° C. and slowly added powdered potassium hydroxide (6.8 g) with vigorous stirring. After continuing stirring at this temperature for another hour, the solvent was distilled off under reduced pressure. The obtained residue was dissolved in water (50 ml) and heated under reflux for 2 hours. Under ice cooling, the pH was adjusted to 3.5 using 1N-hydrochloric acid. The white precipitate was collected by filtration, washed with a small amount of water, and dried under vacuum to obtain the desired product (2.2 g). 1 H-NMR (CDCl 3 : CD 3 OD = 1: 1, δ
Value): 2.95 (3H, s), 6.74 (1H, d, J
= 9.0 Hz), 7.96-8.12 (2H, m)

【0099】[0099]

【参考例23】4−メチルアミノ−3−トリフルオロメチル安息香酸メ
チルエステルの合成 参考例22の化合物(2.2g)のメタノール溶液(2
5ml)に、氷冷下、塩化水素ガスを吹き込み、室温
で、4時間攪拌を続けた。減圧下で溶媒を留去し、得ら
れた残渣を酢酸エチルに溶解した。この溶液を飽和炭酸
水素ナトリウム水溶液で洗浄し、無水硫酸マグネシウム
で乾燥した後、減圧下で溶媒を留去した。得られた残渣
をシリカゲルクロマトグラフィーに付し、溶出溶媒とし
て酢酸エチル:ノルマルヘキサン=1:3を用いて、目
的物(1.3g)を得た。 H−NMR(CDCl,δ値):2.91(3H,
s),3.83(3H,s),4.63(1H,b
s),6.65(1H,d,J=9.0Hz),7.9
2−8.99(2H,m)
[Reference Example 23] 4-Methylamino-3-trifluoromethylbenzoic acid
Synthesis of Cyl Ester A methanol solution of the compound of Reference Example 22 (2.2 g) (2
5 ml) was blown with hydrogen chloride gas under ice-cooling, and stirring was continued at room temperature for 4 hours. The solvent was distilled off under reduced pressure, and the obtained residue was dissolved in ethyl acetate. The solution was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel chromatography, and the desired product (1.3 g) was obtained using ethyl acetate: normal hexane = 1: 3 as an elution solvent. 1 H-NMR (CDCl 3 , δ value): 2.91 (3H,
s), 3.83 (3H, s), 4.63 (1H, b
s), 6.65 (1H, d, J = 9.0 Hz), 7.9
2-8.99 (2H, m)

【0100】[0100]

【参考例24】4−[N−(2,4−ジアミノ−6−プテリジニル)メ
チル−N−メチル]アミノ−3−トリフルオロメチル安
息香酸の合成 参考例23の化合物(1.3g)のヘキサメチルフォス
フォリックトリアミド溶液(20ml)に、氷冷、窒素
雰囲気下、水素化ナトリウム(0.26g)を加え30
分撹拌した。この反応液に、6−ブロモメチル−2,4
−ジアミノプテリジン臭化水素酸塩1/3イソプロパノ
ール付加物(2.8g)を加えた後30分攪拌し、さら
に70℃で6時間、室温で2旦間攪拌した。反応液を希
塩酸にあけ、飽和炭酸水素ナトリウム水溶液で中和し、
得られた褐色沈殿物を濾取した。真空乾燥した後、クロ
ロホルム:メタノール=1:1混合溶媒に懸濁し、1時
間加熱還流した。不溶物を濾去し、濾液を減圧下で濃縮
乾固した。得られた残渣をメタノール(50ml)に溶
解し、1N−水酸化ナトリウム水溶液(20ml)を加
え、60℃で1時間撹拌した。減圧下でメタノールを留
去した後、不溶物を濾取した。氷冷下、1N−塩酸を用
いてpH=4に調節した。橙色沈殿物を濾取し、真空乾
燥した後、シリカゲルクロマトグラフィーに付した。溶
出溶媒として酢酸エチル、次いで、クロロホルム:メタ
ノール:28%アンモニア水=5:4:1を用いて分離
した。目的画分を減圧下で濃縮乾固し、得られた残渣を
水に溶解した。氷冷下、1N−塩酸を用いてpH=4に
調節した後、黄色沈殿物を濾取し、真空乾燥して目的物
(102mg)を得た。
Reference Example 24 4- [N- (2,4-diamino-6-pteridinyl) meth
Tyl-N-methyl] amino-3-trifluoromethyl ammonium
Synthesis of benzoic acid To a solution of the compound of Reference Example 23 (1.3 g) in hexamethylphosphoric triamide (20 ml) was added sodium hydride (0.26 g) under ice-cooling and nitrogen atmosphere.
For a minute. 6-Bromomethyl-2,4
-Diaminopteridine hydrobromide 1/3 isopropanol adduct (2.8 g) was added, and the mixture was stirred for 30 minutes, further stirred at 70 ° C for 6 hours and at room temperature for 2 days. The reaction solution was poured into diluted hydrochloric acid, neutralized with a saturated aqueous solution of sodium hydrogen carbonate,
The resulting brown precipitate was collected by filtration. After vacuum drying, the mixture was suspended in a mixed solvent of chloroform: methanol = 1: 1, and heated under reflux for 1 hour. The insoluble material was removed by filtration, and the filtrate was concentrated to dryness under reduced pressure. The obtained residue was dissolved in methanol (50 ml), a 1N aqueous solution of sodium hydroxide (20 ml) was added, and the mixture was stirred at 60 ° C for 1 hour. After methanol was distilled off under reduced pressure, insolubles were collected by filtration. Under ice cooling, the pH was adjusted to 4 using 1N-hydrochloric acid. The orange precipitate was collected by filtration, dried in vacuo, and then subjected to silica gel chromatography. Separation was performed using ethyl acetate as an elution solvent, and then using chloroform: methanol: 28% aqueous ammonia = 5: 4: 1. The target fraction was concentrated to dryness under reduced pressure, and the obtained residue was dissolved in water. After adjusting the pH to 4 using 1N-hydrochloric acid under ice cooling, the yellow precipitate was collected by filtration and dried in vacuo to obtain the desired product (102 mg).

【0101】H−NMR(DMSO−d=CDCl
=7:1,δ値):2.79(3H,s),4.42
(2H,s),7.61(1H,d,J=8.3H
z),8.11−8.17(2H,m),8.69(1
H,s)
1 H-NMR (DMSO-d 6 = CDCl
3 = 7: 1, δ value): 2.79 (3H, s), 4.42
(2H, s), 7.61 (1H, d, J = 8.3H
z), 8.11-8.17 (2H, m), 8.69 (1
H, s)

【0102】[0102]

【実施例12】N−{4−[N’−(2,4−ジアミノ−6−プテリジ
ニル)メチルーN’−メチル]アミノ−3−トリフルオ
ロメチルベンゾイル}−L−2−アミノアジピン酸の合
(L−2−{N−[4−[N’−(2,4−ジアミノ−
6−プテリジニル)メチル−N’−メチル]アミノ−3
−トリフルオロメチルベンゾイル]}アミノアジピン酸
の合成)
Example 12 N- {4- [N ′-(2,4-diamino-6-pteridi)
Nyl) methyl-N'-methyl] amino-3-trifluoro
Combination of romethylbenzoyl} -L-2-aminoadipic acid
Formation (L-2- {N- [4- [N '- (2,4- diamino -
6-pteridinyl) methyl-N'-methyl] amino-3
-Trifluoromethylbenzoyl] {synthesis of aminoadipic acid)

【0103】参考例24の化合物(88mg)のヘキサ
メチルフォスフォリックトリアミド溶液(2ml)に、
氷冷、窒素雰囲気下、ヒドロキシベンゾトリアゾール
(36mg)、ジシクロヘキシルカルボジイミド(55
mg)を加え30分攪拌した。次いで、L−2−アミノ
アジピン酸ジメチルエステル塩酸塩(63mg)、N−
メチルモルホリン(34mg)を加えた後、徐々に室温
に戻し2日間攪拌した。反応液をシリカゲルクロマトグ
ラフィーに付し、溶出溶媒としてクロロホルム、次いで
クロロホルム:メタノール=19:1を用いて精製し
た。目的画分を減圧下で濃縮乾固し、メタノール(2m
l)に溶解した。氷冷、窒素雰囲気下、1N−水酸化ナ
トリウム水溶液(0.4ml)を加え5時間攪拌した。
減圧下で溶媒を留去し、得られた残渣を水に溶解した。
不溶物を濾去した後、1N−塩酸を用いてpH=3.5
に調節した。黄色沈殿物を濾取し、少量の水で洗浄した
後、真空乾燥した。この粗生成物を分取用薄層クロマト
グラフィー(シリカゲル)に付し、展開溶媒として、ク
ロロホルム:メタノール:28%アンモニア水=5:
4:1を用いて分離した。溶出液を減圧下で濃縮乾固し
た後、炭酸水素ナトリウム水溶液に溶解した。不溶物を
濾去した後、1N−塩酸を用いてpH=3.5に調節し
た。淡黄色沈殿物を濾取し、真空乾燥して目的物(18
mg)を得た。
To a solution of the compound of Reference Example 24 (88 mg) in hexamethylphosphoric triamide (2 ml) was added:
Under ice cooling and nitrogen atmosphere, hydroxybenzotriazole (36 mg), dicyclohexylcarbodiimide (55
mg) and stirred for 30 minutes. Then, L-2-aminoadipic acid dimethyl ester hydrochloride (63 mg), N-
After adding methyl morpholine (34 mg), the mixture was gradually returned to room temperature and stirred for 2 days. The reaction solution was subjected to silica gel chromatography, and purified using chloroform as an elution solvent, and then using chloroform: methanol = 19: 1. The desired fraction was concentrated to dryness under reduced pressure, and methanol (2m
l). Under ice cooling and a nitrogen atmosphere, a 1N aqueous solution of sodium hydroxide (0.4 ml) was added, and the mixture was stirred for 5 hours.
The solvent was distilled off under reduced pressure, and the obtained residue was dissolved in water.
After filtering off the insoluble matter, pH = 3.5 using 1N-hydrochloric acid.
Was adjusted to The yellow precipitate was collected by filtration, washed with a small amount of water, and dried under vacuum. This crude product was subjected to preparative thin-layer chromatography (silica gel), and chloroform: methanol: 28% aqueous ammonia = 5:
Separated using 4: 1. The eluate was concentrated to dryness under reduced pressure and then dissolved in an aqueous sodium hydrogen carbonate solution. After filtering off the insoluble matter, the pH was adjusted to 3.5 using 1N-hydrochloric acid. The pale yellow precipitate was collected by filtration, dried in vacuo and the desired product (18
mg).

【0104】H−NMR(DMSO−d=CDCl
=7:1,δ値):1.53−1,93(4H,
m),2.25(2H,t,J=7.3Hz),2.7
5(3H,s),4.34−4.45(3H,m),
6.91(2H,bs),7.63−7.67(2H,
m),7.95(1H,bs),8.16(1H,d,
J=8.3Hz),8.22(1H,s),8.72
(1H,s),8.79(1H,d,J=7.8Hz)
1 H-NMR (DMSO-d 6 = CDCl
3 = 7: 1, δ value): 1.53-1, 93 (4H,
m), 2.25 (2H, t, J = 7.3 Hz), 2.7
5 (3H, s), 4.34-4.45 (3H, m),
6.91 (2H, bs), 7.63-7.67 (2H,
m), 7.95 (1H, bs), 8.16 (1H, d,
J = 8.3 Hz), 8.22 (1H, s), 8.72
(1H, s), 8.79 (1H, d, J = 7.8 Hz)

【図面の簡単な説明】[Brief description of the drawings]

図1は、被験薬物のそれぞれの濃度におけるH−Ud
Rの取り込み量(割合)を表す。
FIG. 1 shows 3 H-Ud at each concentration of the test drug.
Indicates the amount (ratio) of incorporation of R.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 辻 敬一郎 静岡県御殿場市駒門1丁目135番地 中 外製薬株式会社内 (56)参考文献 ANTIMICROBIAL AGE NTS AND CHEMOTHERA PY,Vol.35,No.7(Jul y,1991)p.1348−1355 (58)調査した分野(Int.Cl.7,DB名) C07D 475/08 CA(STN) CAOLD(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (72) Keiichiro Tsuji 1-135, Komamon, Gotemba, Shizuoka Prefecture Inside Chugai Pharmaceutical Co., Ltd. (56) References ANTIMICROBIAL AGE NTS AND CHEMOTHERA PY, Vol. 35, No. 7 (July, 1991) p. 1348-1355 (58) Fields investigated (Int. Cl. 7 , DB name) C07D 475/08 CA (STN) CAOLD (STN) REGISTRY (STN)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】一般式(I) 【化1】 式中、R1は、炭素数1乃至4の低級アルキル基を示
し; R2は、炭素数1乃至4の低級アルキル基またはトリフ
ルオロメチル基を示し; R3は、水素原子または炭素数1乃至4の低級アルキル
基またはトリフルオロメチル基を示し; R4は、水素原子または炭素数1乃至4の低級アルキル
基を示し; nは1から4までの整数を示し; R5は、一般式COOR6(ここでR6は水素原子または
炭素数1乃至4の低級アルキル基を示す)で表される基
またはSO3Hで表される基を示す; で示される化合物(但し、R1がメチル基、R2がトリフ
ルオロメチル基、R3が水素原子、R4が水素原子、nが
2、R5がCOOR6(R6が水素原子)である化合物を
除く)。
1. A compound of the general formula (I) In the formula, R 1 represents a lower alkyl group having 1 to 4 carbon atoms; R 2 represents a lower alkyl group having 1 to 4 carbon atoms or a trifluoromethyl group; R 3 represents a hydrogen atom or a 1 carbon atom. R 4 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; n represents an integer of 1 to 4; R 5 represents a general formula COOR 6 (wherein R 6 is a hydrogen atom or having 1 to 4 lower alkyl represents a group atoms), a group represented by or SO 3 H a group represented by a compound represented by (wherein, R 1 is A methyl group, R 2 is a trifluoromethyl group, R 3 is a hydrogen atom, R 4 is a hydrogen atom, n is 2, and R 5 is COOR 6 (excluding compounds in which R 6 is a hydrogen atom).
JP04430193A 1992-01-27 1993-01-25 New methotrexate derivatives Expired - Fee Related JP3207285B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04430193A JP3207285B2 (en) 1992-01-27 1993-01-25 New methotrexate derivatives

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP4-53051 1992-01-27
JP5305192 1992-01-27
JP10832092 1992-03-16
JP4-108320 1992-03-16
JP04430193A JP3207285B2 (en) 1992-01-27 1993-01-25 New methotrexate derivatives

Publications (2)

Publication Number Publication Date
JPH05339268A JPH05339268A (en) 1993-12-21
JP3207285B2 true JP3207285B2 (en) 2001-09-10

Family

ID=27291851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04430193A Expired - Fee Related JP3207285B2 (en) 1992-01-27 1993-01-25 New methotrexate derivatives

Country Status (1)

Country Link
JP (1) JP3207285B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015077A1 (en) * 1992-01-27 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Methotrexate derivative
WO2024028999A1 (en) * 2022-08-03 2024-02-08 Ils株式会社 Method for producing n-[4-methylaminobenzoyl]-l-glutamic acid diethyl ester

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,Vol.35,No.7(July,1991)p.1348−1355

Also Published As

Publication number Publication date
JPH05339268A (en) 1993-12-21

Similar Documents

Publication Publication Date Title
EP0632038B1 (en) Methotrexate derivative
EP0354583B1 (en) DC-88A derivatives
JPH06239822A (en) New n-benzoylamino acid derivative, medicinal composition comprising the same compound and production of the same compound
EP0014437A2 (en) Novel 1-aryl-2-acylamido-3-fluoro-1-propanols, their preparation and pharmaceutical compositions containing them
EP0118913B1 (en) Porphyrin derivatives
US4140788A (en) N-Substituted imidazolecarboxamide derivatives
KR890004132B1 (en) Process of preparing chromoglyic acid derivatives
JP2970698B2 (en) Conjugates of difluoroglutamic acid with formates and antifolates for the treatment of neoplastic diseases
JP3207285B2 (en) New methotrexate derivatives
JPS6147838B2 (en)
EP0548177B1 (en) 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
US5728692A (en) Methotrexate derivative
JPH0228143A (en) Amide compound, production thereof and inhibitor of glutamic acid receptor
JP3274532B2 (en) Anti-rheumatic drug
US5399590A (en) Quaternary ammonium salts and pharmaceutical compositions containing them
JP3359722B2 (en) Methotrexate derivative
JPH0597841A (en) Isocoumarin derivative
JPH07242670A (en) Pyrrolo(3,2-e)pyrazolo(1,5-a)pyrimidine derivative and circulatory disease-treating agent using the same
JP3100469B2 (en) Psoriasis treatment
JPH05194517A (en) 6-mercaptopurine derivative and its production
JP3145533B2 (en) New methotrexate derivatives
US5250526A (en) Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
EP0378706A1 (en) 5-substituted uridine derivatives and intermediates for their preparation
JPH0359899B2 (en)
JPS6330462A (en) Novel guanidinomethylbenzamide derivative and antiulcer agent containing said derivative as active ingredient

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees